Table of Contents
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) | |
| |
||
(Address of principal executive offices) |
(Zip Code) | |
| Title of Each Class |
Trading Symbol |
Name of each exchange on which registered | ||
☒ |
Accelerated filer |
☐ | ||||
Non-accelerated filer |
☐ |
Smaller reporting company |
||||
Emerging growth company |
||||||
Table of Contents
TABLE OF CONTENTS
| Page | ||||||
| PART I—FINANCIAL INFORMATION |
||||||
| Item 1. |
Financial Statements: | |||||
| Condensed Consolidated Balance Sheets as of March 31, 2024 (Unaudited) and December 31, 2023 |
3 | |||||
| 4 | ||||||
| 5 | ||||||
| 6 | ||||||
| 7 | ||||||
| Notes to Condensed Consolidated Financial Statements (Unaudited) |
8 | |||||
| 8 | ||||||
| 9 | ||||||
| 10 | ||||||
| 11 | ||||||
| 24 | ||||||
| 29 | ||||||
| 49 | ||||||
| 49 | ||||||
| 54 | ||||||
| 57 | ||||||
| 58 | ||||||
| 60 | ||||||
| 60 | ||||||
| 62 | ||||||
| 62 | ||||||
| 65 | ||||||
| Note 17 — Changes in Accumulated Other Comprehensive Income (Loss) |
70 | |||||
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
72 | ||||
| Item 3. | 111 | |||||
| Item 4. | 111 | |||||
| PART II—OTHER INFORMATION |
||||||
| Item 1. | 112 | |||||
| Item 1A. | 112 | |||||
| Item 2. | 112 | |||||
| Item 5. | 112 | |||||
| Item 6. | 113 | |||||
| Signatures | 114 | |||||
2
Table of Contents
Item 1. |
Financial Statements |
March 31, 2024 |
December 31, 2023 |
|||||||
(Unaudited) |
||||||||
Assets |
||||||||
Investments: |
||||||||
Fixed maturity securities available-for-sale, at fair value (amortized cost of $ |
$ | $ | ||||||
Equity securities, at fair value |
||||||||
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $ |
||||||||
Less: Allowance for credit losses |
( |
) | ( |
) | ||||
Commercial mortgage loans, net |
||||||||
Policy loans |
||||||||
Limited partnerships |
||||||||
Other invested assets |
||||||||
Total investments |
||||||||
Cash, cash equivalents and restricted cash |
||||||||
Accrued investment income |
||||||||
Deferred acquisition costs |
||||||||
Intangible assets |
||||||||
Reinsurance recoverable |
||||||||
Less: Allowance for credit losses |
( |
) | ( |
) | ||||
Reinsurance recoverable, net |
||||||||
Other assets |
||||||||
Deferred tax asset |
||||||||
Market risk benefit assets |
||||||||
Separate account assets |
||||||||
Total assets |
$ | $ | ||||||
Liabilities and equity |
||||||||
Liabilities: |
||||||||
Future policy benefits |
$ | $ | ||||||
Policyholder account balances |
||||||||
Market risk benefit liabilities |
||||||||
Liability for policy and contract claims |
||||||||
Unearned premiums |
||||||||
Other liabilities |
||||||||
Long-term borrowings |
||||||||
Separate account liabilities |
||||||||
Total liabilities |
||||||||
Commitments and contingencies (Note 16) |
||||||||
Equity: |
||||||||
Class A common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated other comprehensive income (loss) |
( |
) | ( |
) | ||||
Retained earnings |
||||||||
Treasury stock, at cost ( |
( |
) | ( |
) | ||||
Total Genworth Financial, Inc.’s stockholders’ equity |
||||||||
Noncontrolling interests |
||||||||
Total equity |
||||||||
Total liabilities and equity |
$ | $ | ||||||
Three months ended March 31, |
||||||||
2024 |
2023 |
|||||||
| Revenues: |
||||||||
| Premiums |
$ | $ | ||||||
| Net investment income |
||||||||
| Net investment gains (losses) |
( |
) | ||||||
| Policy fees and other income |
||||||||
| |
|
|
|
|||||
| Total revenues |
||||||||
| |
|
|
|
|||||
| Benefits and expenses: |
||||||||
| Benefits and other changes in policy reserves |
||||||||
| Liability remeasurement (gains) losses |
( |
) | ( |
) | ||||
| Changes in fair value of market risk benefits and associated hedges |
( |
) | ||||||
| Interest credited |
||||||||
| Acquisition and operating expenses, net of deferrals |
||||||||
| Amortization of deferred acquisition costs and intangibles |
||||||||
| Interest expense |
||||||||
| |
|
|
|
|||||
| Total benefits and expenses |
||||||||
| |
|
|
|
|||||
| Income from continuing operations before income taxes |
||||||||
| Provision for income taxes |
||||||||
| |
|
|
|
|||||
| Income from continuing operations |
||||||||
| Loss from discontinued operations, net of taxes |
( |
) | ||||||
| |
|
|
|
|||||
| Net income |
||||||||
| Less: net income attributable to noncontrolling interests |
||||||||
| |
|
|
|
|||||
| Net income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
| |
|
|
|
|||||
| Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||
| Basic |
$ | $ | ||||||
| |
|
|
|
|||||
| Diluted |
$ | $ | ||||||
| |
|
|
|
|||||
| Net income available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||
| Basic |
$ | $ | ||||||
| |
|
|
|
|||||
| Diluted |
$ | $ | ||||||
| |
|
|
|
|||||
| Weighted-average common shares outstanding: |
||||||||
| Basic |
||||||||
| |
|
|
|
|||||
| Diluted |
||||||||
| |
|
|
|
|||||
Three months ended March 31, |
||||||||
2024 |
2023 |
|||||||
| Net income |
$ | $ | ||||||
| Other comprehensive income (loss), net of taxes: |
||||||||
| Net unrealized gains (losses) on securities without an allowance for credit losses |
( |
) | ||||||
| Net unrealized gains (losses) on securities with an allowance for credit losses |
( |
) | ||||||
| Derivatives qualifying as hedges |
( |
) | ||||||
| Change in the discount rate used to measure future policy benefits |
( |
) | ||||||
| Change in instrument-specific credit risk of market risk benefits |
||||||||
| Foreign currency translation and other adjustments |
||||||||
| |
|
|
|
|||||
| Total other comprehensive income (loss) |
( |
) | ||||||
| |
|
|
|
|||||
| Total comprehensive income (loss) |
( |
) | ||||||
| Less: comprehensive income attributable to noncontrolling interests |
||||||||
| |
|
|
|
|||||
| Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ( |
) | ||||
| |
|
|
|
|||||
Three months ended March 31, 2024 |
||||||||||||||||||||||||||||||||
Common stock |
Additional paid-in capital |
Accumulated other comprehensive income (loss) |
Retained earnings |
Treasury stock, at cost |
Total Genworth Financial, Inc.’s stockholders’ equity |
Noncontrolling interests |
Total equity |
|||||||||||||||||||||||||
| Balances as of December 31, 2023 |
$ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||
| Repurchase of subsidiary shares |
( |
) | ( |
) | ||||||||||||||||||||||||||||
| Comprehensive income (loss): |
||||||||||||||||||||||||||||||||
| Net income |
||||||||||||||||||||||||||||||||
| Other comprehensive income (loss), net of taxes |
( |
) | ||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|||||||||||||||||||||||||||
| Total comprehensive income |
||||||||||||||||||||||||||||||||
| Treasury stock acquired in connection with share repurchases |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
| Dividends to noncontrolling interests |
( |
) | ( |
) | ||||||||||||||||||||||||||||
| Stock-based compensation expense and exercises and other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Balances as of March 31, 2024 |
$ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Three months ended March 31, 2023 |
||||||||||||||||||||||||||||||||
Common stock |
Additional paid-in capital |
Accumulated other comprehensive income (loss) |
Retained earnings |
Treasury stock, at cost |
Total Genworth Financial, Inc.’s stockholders’ equity |
Noncontrolling interests |
Total equity |
|||||||||||||||||||||||||
| Balances as of December 31, 2022 |
$ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||
| Repurchase of subsidiary shares |
( |
) | ( |
) | ||||||||||||||||||||||||||||
| Comprehensive income (loss): |
||||||||||||||||||||||||||||||||
| Net income |
||||||||||||||||||||||||||||||||
| Other comprehensive income (loss), net of taxes |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
| |
|
|
|
|
|
|||||||||||||||||||||||||||
| Total comprehensive income (loss) |
( |
) | ( |
) | ||||||||||||||||||||||||||||
| Treasury stock acquired in connection with share repurchases |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
| Dividends to noncontrolling interests |
( |
) | ( |
) | ||||||||||||||||||||||||||||
| Stock-based compensation expense and exercises and other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Balances as of March 31, 2023 |
$ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Three months ended March 31, |
||||||||
2024 |
2023 |
|||||||
| Cash flows from (used by) operating activities: |
||||||||
| Net income |
$ | $ | ||||||
| Less loss from discontinued operations, net of taxes |
||||||||
| Adjustments to reconcile net income to net cash from (used by) operating activities: |
||||||||
| Amortization of fixed maturity securities discounts and premiums |
( |
) | ( |
) | ||||
| Net investment (gains) losses |
( |
) | ||||||
| Changes in fair value of market risk benefits and associated hedges |
( |
) | ||||||
| Charges assessed to policyholders |
( |
) | ( |
) | ||||
| Amortization of deferred acquisition costs and intangibles |
||||||||
| Deferred income taxes |
( |
) | ||||||
| Derivative instruments, limited partnerships and other |
( |
) | ( |
) | ||||
| Long-term incentive compensation expense |
||||||||
| Change in certain assets and liabilities: |
||||||||
| Accrued investment income and other assets |
( |
) | ( |
) | ||||
| Insurance reserves |
||||||||
| Current tax liabilities |
||||||||
| Other liabilities, policy and contract claims and other policy-related balances |
( |
) | ( |
) | ||||
| Cash used by operating activities—discontinued operations |
( |
) | ||||||
| |
|
|
|
|||||
| Net cash from (used by) operating activities |
( |
) | ||||||
| |
|
|
|
|||||
| Cash flows from (used by) investing activities: |
||||||||
| Proceeds from maturities and repayments of investments: |
||||||||
| Fixed maturity securities |
||||||||
| Commercial mortgage loans |
||||||||
| Limited partnerships and other invested assets |
||||||||
| Proceeds from sales of investments: |
||||||||
| Fixed maturity and equity securities |
||||||||
| Purchases and originations of investments: |
||||||||
| Fixed maturity and equity securities |
( |
) | ( |
) | ||||
| Commercial mortgage loans |
( |
) | ( |
) | ||||
| Limited partnerships and other invested assets |
( |
) | ( |
) | ||||
| Short-term investments, net |
||||||||
| Policy loans, net |
||||||||
| Other |
( |
) | ||||||
| |
|
|
|
|||||
| Net cash from investing activities |
||||||||
| |
|
|
|
|||||
| Cash flows from (used by) financing activities: |
||||||||
| Deposits to universal life and investment contracts |
||||||||
| Withdrawals from universal life and investment contracts |
( |
) | ( |
) | ||||
| Repayment and repurchase of long-term debt |
( |
) | ( |
) | ||||
| Repurchase of subsidiary shares |
( |
) | ( |
) | ||||
| Treasury stock acquired in connection with share repurchases |
( |
) | ( |
) | ||||
| Dividends paid to noncontrolling interests |
( |
) | ( |
) | ||||
| Other, net |
( |
) | ||||||
| |
|
|
|
|||||
| Net cash used by financing activities |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Net change in cash, cash equivalents and restricted cash |
( |
) | ( |
) | ||||
| Cash, cash equivalents and restricted cash at beginning of period |
||||||||
| |
|
|
|
|||||
| Cash, cash equivalents and restricted cash at end of period |
$ | $ | ||||||
| |
|
|
|
|||||
| • | Enact |
| • | Long-Term Care Insurance. |
| • | Life and Annuities. |
Three months ended March 31, |
||||||||
| (Amounts in millions, except per share amounts) |
2024 |
2023 |
||||||
| Weighted-average common shares used in basic earnings per share calculations |
||||||||
| Potentially dilutive securities: |
||||||||
| Performance stock units, restricted stock units and other equity-based awards |
||||||||
| |
|
|
|
|||||
| Weighted-average common shares used in diluted earnings per share calculations |
||||||||
| |
|
|
|
|||||
| Income from continuing operations: |
||||||||
| Income from continuing operations |
$ | $ | ||||||
| Less: net income from continuing operations attributable to noncontrolling interests |
||||||||
| |
|
|
|
|||||
| Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
| |
|
|
|
|||||
| Basic per share |
$ | $ | ||||||
| |
|
|
|
|||||
| Diluted per share |
$ | $ | ||||||
| |
|
|
|
|||||
| Loss from discontinued operations: |
||||||||
| Loss from discontinued operations, net of taxes |
$ | ( |
) | $ | ||||
| |
|
|
|
|||||
| Basic per share |
$ | $ | ||||||
| |
|
|
|
|||||
| Diluted per share |
$ | $ | ||||||
| |
|
|
|
|||||
| Net income: |
||||||||
| Income from continuing operations |
$ | $ | ||||||
| Loss from discontinued operations, net of taxes |
( |
) | ||||||
| |
|
|
|
|||||
| Net income |
||||||||
| Less: net income attributable to noncontrolling interests |
||||||||
| |
|
|
|
|||||
| Net income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
| |
|
|
|
|||||
| Basic per share (1) |
$ | $ | ||||||
| |
|
|
|
|||||
| Diluted per share |
$ | $ | ||||||
| |
|
|
|
|||||
(1) |
May not total due to whole number calculation. |
Three months ended March 31, |
||||||||
| (Amounts in millions) |
2024 |
2023 |
||||||
| Fixed maturity securities—taxable |
$ | $ | ||||||
| Fixed maturity securities—non-taxable |
||||||||
| Equity securities |
||||||||
| Commercial mortgage loans |
||||||||
| Policy loans |
||||||||
| Limited partnerships |
||||||||
| Other invested assets |
||||||||
| Cash, cash equivalents, restricted cash and short-term investments |
||||||||
| |
|
|
|
|||||
| Gross investment income before expenses and fees |
||||||||
| Expenses and fees |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Net investment income |
$ | $ | ||||||
| |
|
|
|
|||||
Three months ended March 31, |
||||||||
| (Amounts in millions) |
2024 |
2023 |
||||||
| Realized investment gains (losses): |
||||||||
| Available-for-sale fixed maturity securities: |
||||||||
| Realized gains |
$ | $ | ||||||
| Realized losses |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Net realized gains (losses) on available-for-sale fixed maturity securities |
( |
) | ( |
) | ||||
| Net realized gains (losses) on equity securities sold |
||||||||
| |
|
|
|
|||||
| Total net realized investment gains (losses) |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Net change in allowance for credit losses on available-for-sale fixed maturity securities |
( |
) | ||||||
| Net unrealized gains (losses) on equity securities still held |
||||||||
| Net unrealized gains (losses) on limited partnerships |
||||||||
| Commercial mortgage loans |
( |
) | ( |
) | ||||
| Derivative instruments (1) |
||||||||
| Other |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Net investment gains (losses) |
$ | $ | ( |
) | ||||
| |
|
|
|
|||||
(1) |
See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses). |
| (Amounts in millions) |
Beginning balance |
Increase from securities without allowance in previous periods |
Increase (decrease) from securities with allowance in previous periods |
Securities sold |
Decrease due to change in intent or requirement to sell |
Write-offs |
Recoveries |
Ending balance |
||||||||||||||||||||||||
| Fixed maturity securities: |
||||||||||||||||||||||||||||||||
| Commercial mortgage-backed |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Total available-for-sale securities |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| (Amounts in millions) |
Beginning balance |
Increase from securities without allowance in previous periods |
Increase (decrease) from securities with allowance in previous periods |
Securities sold |
Decrease due to change in intent or requirement to sell |
Write-offs |
Recoveries |
Ending balance |
||||||||||||||||||||||||
| Fixed maturity securities: |
||||||||||||||||||||||||||||||||
| U.S. corporate |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Commercial mortgage-backed |
||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Total available-for-sale securities |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| (Amounts in millions) |
March 31, 2024 |
December 31, 2023 |
||||||
| Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses |
$ | ( |
) | $ | ( |
) | ||
| Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses |
||||||||
| Adjustments to policyholder contract balances |
||||||||
| Income taxes, net |
||||||||
| |
|
|
|
|||||
| Net unrealized investment gains (losses) |
( |
) | ( |
) | ||||
| Less: net unrealized investment gains (losses) attributable to noncontrolling interests |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. |
$ | ( |
) | $ | ( |
) | ||
| |
|
|
|
|||||
| (Amounts in millions) |
2024 |
2023 |
||||||
| Beginning balance |
$ | ( |
) | $ | ( |
) | ||
| Unrealized gains (losses) arising during the period: |
||||||||
| Unrealized gains (losses) on fixed maturity securities |
( |
) | ||||||
| Adjustments to policyholder contract balances (1) |
( |
) | ||||||
| Provision for income taxes |
( |
) | ||||||
| |
|
|
|
|||||
| Change in unrealized gains (losses) on investment securities |
( |
) | ||||||
| Reclassification adjustments to net investment (gains) losses, net of taxes of $( |
||||||||
| |
|
|
|
|||||
| Change in net unrealized investment gains (losses) |
( |
) | ||||||
| Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests |
( |
) | ||||||
| |
|
|
|
|||||
| Ending balance |
$ | ( |
) | $ | ( |
) | ||
| |
|
|
|
|||||
(1) |
See note 10 for additional information. |
(Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
State and political subdivisions |
( |
) | ||||||||||||||||||
Non-U.S. government |
( |
) | ||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
( |
) | ||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||
Other |
( |
) | ||||||||||||||||||
Total U.S. corporate |
( |
) | ||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
( |
) | ||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||
Other |
( |
) | ||||||||||||||||||
Total non-U.S. corporate |
( |
) | ||||||||||||||||||
Residential mortgage-backed |
( |
) | ||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ||||||||||||||||
Other asset-backed |
( |
) | ||||||||||||||||||
Total available-for-sale securities |
$ | $ | $ | ( |
) | $ | ( |
) | $ | |||||||||||
(Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
State and political subdivisions |
( |
) | ||||||||||||||||||
Non-U.S. government |
( |
) | ||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
( |
) | ||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||
Other |
( |
) | ||||||||||||||||||
Total U.S. corporate |
( |
) | ||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
( |
) | ||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||
Other |
( |
) | ||||||||||||||||||
Total non-U.S. corporate |
( |
) | ||||||||||||||||||
Residential mortgage-backed |
( |
) | ||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ||||||||||||||||
Other asset-backed |
( |
) | ||||||||||||||||||
Total available-for-sale securities |
$ | $ | $ | ( |
) | $ | ( |
) | $ | |||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
State and political subdivisions |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. government |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
% Below cost: |
||||||||||||||||||||||||||||||||||||
<20% Below cost |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
20%-50% Below cost |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Investment grade |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Below investment grade |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Utilities |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Subtotal, U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Subtotal, non-U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
| (Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
| Description of Securities |
||||||||||||||||||||||||||||||||||||
| Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||
| U.S. government, agencies and government-sponsored enterprises |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
| State and political subdivisions |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Non-U.S. government |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Non-U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Residential mortgage-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Commercial mortgage-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Other asset-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| % Below cost: |
||||||||||||||||||||||||||||||||||||
| <20% Below cost |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
| 20%-50% Below cost |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Investment grade |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
| Below investment grade |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total for in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
| (Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
| Description of Securities |
|
|||||||||||||||||||||||||||||||||||
| U.S. corporate: |
||||||||||||||||||||||||||||||||||||
| Utilities |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
| Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Finance and insurance |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Consumer—non-cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Technology and communications |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Industrial |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Transportation |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Other |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Subtotal, U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||
| Utilities |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Finance and insurance |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| Technology and communications |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| Industrial |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| Transportation |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| Other |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Subtotal, non-U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total for in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
(Amounts in millions) |
Amortized cost or cost |
Fair value |
||||||
Due one year or less |
$ | $ | ||||||
Due after one year through five years |
||||||||
Due after five years through ten years |
||||||||
Due after ten years |
||||||||
Subtotal |
||||||||
Residential mortgage-backed |
||||||||
Commercial mortgage-backed |
||||||||
Other asset-backed |
||||||||
Total |
$ | $ | ||||||
March 31, 2024 |
December 31, 2023 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Property type: |
||||||||||||||||
Retail |
$ | % | $ | % | ||||||||||||
Office |
||||||||||||||||
Industrial |
||||||||||||||||
Apartments |
||||||||||||||||
Mixed use |
||||||||||||||||
Other |
||||||||||||||||
Subtotal |
% | % | ||||||||||||||
Allowance for credit losses |
( |
) | ( |
) | ||||||||||||
Total |
$ | $ | ||||||||||||||
March 31, 2024 |
December 31, 2023 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Geographic region: |
||||||||||||||||
South Atlantic |
$ | % | $ | % | ||||||||||||
Pacific |
||||||||||||||||
Mountain |
||||||||||||||||
Middle Atlantic |
||||||||||||||||
West South Central |
||||||||||||||||
East North Central |
||||||||||||||||
West North Central |
||||||||||||||||
East South Central |
||||||||||||||||
New England |
||||||||||||||||
Subtotal |
% | % | ||||||||||||||
Allowance for credit losses |
( |
) | ( |
) | ||||||||||||
Total |
$ | $ | ||||||||||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2024 |
2023 |
||||||
Allowance for credit losses: |
||||||||
Beginning balance |
$ | $ | ||||||
Provision |
||||||||
Write-offs |
||||||||
Recoveries |
||||||||
Ending balance |
$ | $ | ||||||
(Amounts in millions) |
2024 |
2023 |
2022 |
2021 |
2020 |
2019 and prior |
Total |
|||||||||||||||||||||
Debt-to-value: |
||||||||||||||||||||||||||||
0% - 50% |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
51% - 60% |
||||||||||||||||||||||||||||
61% - 75% |
||||||||||||||||||||||||||||
76% - 100% |
||||||||||||||||||||||||||||
Greater than 100% |
||||||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Debt service coverage ratio: |
||||||||||||||||||||||||||||
Less than 1.00 |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
1.00 - 1.25 |
||||||||||||||||||||||||||||
1.26 - 1.50 |
||||||||||||||||||||||||||||
1.51 - 2.00 |
||||||||||||||||||||||||||||
Greater than 2.00 |
||||||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
March 31, 2024 |
||||||||||||||||||||||||
(Amounts in millions) |
0% - 50% |
51% - 60% |
61% - 75% |
76% - 100% |
Greater than 100% |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Office |
||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
Weighted-average debt service coverage ratio |
||||||||||||||||||||||||
December 31, 2023 |
||||||||||||||||||||||||
(Amounts in millions) |
0% - 50% |
51% - 60% |
61% - 75% |
76% - 100% |
Greater than 100% |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Office |
||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
Weighted-average debt service coverage ratio |
||||||||||||||||||||||||
March 31, 2024 |
||||||||||||||||||||||||
(Amounts in millions) |
Less than 1.00 |
1.00 - 1.25 |
1.26 - 1.50 |
1.51 - 2.00 |
Greater than 2.00 |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Office |
||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
Weighted-average debt-to-value |
% | % | % | % | % | % | ||||||||||||||||||
December 31, 2023 |
||||||||||||||||||||||||
(Amounts in millions) |
Less than 1.00 |
1.00 - 1.25 |
1.26 - 1.50 |
1.51 - 2.00 |
Greater than 2.00 |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Office |
||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
Weighted-average debt-to-value |
% | % | % | % | % | % | ||||||||||||||||||
Derivative assets |
Derivative liabilities |
|||||||||||||||||||
Fair value |
Fair value |
|||||||||||||||||||
(Amounts in millions) |
Balance sheet classification |
March 31, 2024 |
December 31, 2023 |
Balance sheet classification |
March 31, 2024 |
December 31, 2023 |
||||||||||||||
Derivatives designated as hedges |
||||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||||
Interest rate swaps |
Other invested assets | $ | $ | Other liabilities | $ | $ | ||||||||||||||
Foreign currency swaps |
Other invested assets | Other liabilities | ||||||||||||||||||
Forward bond purchase commitments |
Other invested assets | Other liabilities | ||||||||||||||||||
Total cash flow hedges |
||||||||||||||||||||
Total derivatives designated as hedges |
||||||||||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
Equity index options |
Other invested assets | Other liabilities | ||||||||||||||||||
Financial futures (1) |
Other invested assets | Other liabilities | ||||||||||||||||||
Forward bond purchase commitments |
Other invested assets | Other liabilities | ||||||||||||||||||
Fixed indexed annuity embedded derivatives |
Other assets | Policyholder account balances (2) |
||||||||||||||||||
Indexed universal life embedded derivatives |
Reinsurance recoverable | Policyholder account balances (3) |
||||||||||||||||||
Total derivatives not designated as hedges |
||||||||||||||||||||
Total derivatives |
$ | $ | $ | $ | ||||||||||||||||
(1) |
The period end valuations of financial futures were zero as a result of settling the margins on these contracts on a daily basis. |
(2) |
Represents the embedded derivatives associated with our fixed indexed annuity liabilities. |
(3) |
Represents the embedded derivatives associated with our indexed universal life liabilities. |
December 31, |
Maturities/ |
March 31, |
||||||||||||||||
(Notional in millions) |
Measurement |
2023 |
Additions |
terminations |
2024 |
|||||||||||||
Derivatives designated as hedges |
||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||
Interest rate swaps |
Notional | $ | $ | $ | ( |
) | $ | |||||||||||
Foreign currency swaps |
Notional | |||||||||||||||||
Forward bond purchase commitments |
Notional | |||||||||||||||||
Total cash flow hedges |
( |
) | ||||||||||||||||
Total derivatives designated as hedges |
( |
) | ||||||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||
Equity index options |
Notional | ( |
) | |||||||||||||||
Financial futures |
Notional | ( |
) | |||||||||||||||
Forward bond purchase commitments |
Notional | |||||||||||||||||
Total derivatives not designated as hedges |
( |
) | ||||||||||||||||
Total derivatives |
$ | $ | $ | ( |
) | $ | ||||||||||||
December 31, |
Maturities/ |
March 31, |
||||||||||||||||
(Number of policies) |
Measurement |
2023 |
Additions |
terminations |
2024 |
|||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||
Fixed indexed annuity embedded derivatives |
Policies | ( |
) | |||||||||||||||
Indexed universal life embedded derivatives |
Policies | ( |
) | |||||||||||||||
(Amounts in millions) |
Gain (loss) recognized in OCI |
Gain (loss) reclassified into net income from OCI |
Classification of gain (loss) reclassified into net income |
Gain (loss) recognized in net income |
Classification of gain (loss) recognized in net income | |||||||||||
Interest rate swaps hedging assets |
$ | ( |
) | $ | Net investment income | $ | Net investment gains (losses) | |||||||||
Interest rate swaps hedging assets |
Net investment gains (losses) | Net investment gains (losses) | ||||||||||||||
Interest rate swaps hedging liabilities |
( |
) | Interest expense | Net investment gains (losses) | ||||||||||||
Foreign currency swaps |
Net investment income | Net investment gains (losses) | ||||||||||||||
Forward bond purchase commitments |
( |
) | Net investment gains (losses) | Net investment gains (losses) | ||||||||||||
Total |
$ | ( |
) | $ | $ | |||||||||||
(Amounts in millions) |
Gain (loss) recognized in OCI |
Gain (loss) reclassified into net income from OCI |
Classification of gain (loss) reclassified into net income |
Gain (loss) recognized in net income |
Classification of gain (loss) recognized in net income | |||||||||||
Interest rate swaps hedging assets |
$ | $ | Net investment income | $ | Net investment gains (losses) | |||||||||||
Interest rate swaps hedging assets |
Net investment gains (losses) | Net investment gains (losses) | ||||||||||||||
Interest rate swaps hedging liabilities |
( |
) | Interest expense | Net investment gains (losses) | ||||||||||||
Interest rate swaps hedging liabilities |
Net investment gains (losses) | Net investment gains (losses) | ||||||||||||||
Foreign currency swaps |
( |
) | Net investment income | Net investment gains (losses) | ||||||||||||
Forward currency swaps |
Net investment gains (losses) | Net investment gains (losses) | ||||||||||||||
Total |
$ | $ | $ | |||||||||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2024 |
2023 |
||||||
Derivatives qualifying as effective accounting hedges as of January 1 |
$ | $ | ||||||
Current period increases (decreases) in fair value, net of deferred taxes of $ |
( |
) | ||||||
Reclassification to net (income), net of deferred taxes of $ |
( |
) | ( |
) | ||||
Derivatives qualifying as effective accounting hedges as of March 31 |
$ | $ | ||||||
Three months ended |
||||||||||
March 31, |
Classification of gain (loss) recognized in net income | |||||||||
(Amounts in millions) |
2024 |
2023 |
||||||||
Equity index options |
$ | $ | Net investment gains (losses) | |||||||
Financial futures |
( |
) | ( |
) | Changes in fair value of market risk benefits and associated hedges | |||||
Forward bond purchase commitments |
( |
) | Net investment gains (losses) | |||||||
Fixed index annuity embedded derivatives |
( |
) | ( |
) | Net investment gains (losses) | |||||
Indexed universal life embedded derivatives |
Net investment gains (losses) | |||||||||
Total derivatives not designated as hedges |
$ | ( |
) | $ | ||||||
March 31, 2024 |
December 31, 2023 |
|||||||||||||||||||||||
(Amounts in millions) |
Derivative assets (1) |
Derivative liabilities (1) |
Net derivatives |
Derivative assets (1) |
Derivative liabilities (1) |
Net derivatives |
||||||||||||||||||
Amounts presented in the balance sheet: |
||||||||||||||||||||||||
Gross amounts recognized |
$ | $ | $ | ( |
) | $ | $ | $ | ( |
) | ||||||||||||||
Gross amounts offset in the balance sheet |
||||||||||||||||||||||||
Net amounts presented in the balance sheet |
( |
) | ( |
) | ||||||||||||||||||||
Gross amounts not offset in the balance sheet: |
||||||||||||||||||||||||
Financial instruments (2) |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Collateral received |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Collateral pledged |
( |
) | ( |
) | ||||||||||||||||||||
Over collateralization |
( |
) | ( |
) | ||||||||||||||||||||
Net amount |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
(1) |
Does not include amounts related to embedded derivatives as of March 31, 2024 and December 31, 2023. |
(2) |
Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty. |
| • | Third-party pricing services: |
(Amounts in millions) |
Fair value |
Primary methodologies |
Significant inputs | |||||
U.S. government, agencies and government-sponsored enterprises |
$ | |||||||
State and political subdivisions |
$ | |||||||
Non-U.S. government |
$ | bid-offer spread, market research publications, third-party pricing sources | ||||||
U.S. corporate |
$ | |||||||
Non-U.S. corporate |
$ | bid-offer spread, market research publications, third-party pricing sources | ||||||
Residential mortgage-backed |
$ | |||||||
Commercial mortgage-backed |
$ | weighted-average life, cash flows, spreads derived from broker quotes, bid side prices, spreads to daily updated swaps curves, TRACE reports | ||||||
Other asset-backed |
$ | |||||||
| • | Internal models: |
| • | Broker quotes: |
| • | Internal models: |
March 31, 2024 |
||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
NAV (1) |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | $ | $ | |||||||||||||||
State and political subdivisions |
||||||||||||||||||||
Non-U.S. government |
||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
Total U.S. corporate |
||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
Total non-U.S. corporate |
||||||||||||||||||||
Residential mortgage-backed |
||||||||||||||||||||
Commercial mortgage-backed |
||||||||||||||||||||
Other asset-backed |
||||||||||||||||||||
Total fixed maturity securities |
||||||||||||||||||||
Equity securities |
||||||||||||||||||||
Limited partnerships |
||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||
Interest rate swaps |
||||||||||||||||||||
Foreign currency swaps |
||||||||||||||||||||
Equity index options |
||||||||||||||||||||
Forward bond purchase commitments |
||||||||||||||||||||
Total derivative assets |
||||||||||||||||||||
Short-term investments |
||||||||||||||||||||
Total other invested assets |
||||||||||||||||||||
Separate account assets |
||||||||||||||||||||
Total assets |
$ | $ | $ | $ | $ | |||||||||||||||
(1) |
Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. |
December 31, 2023 |
||||||||||||||||||||
| (Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
NAV (1) |
|||||||||||||||
| Assets |
||||||||||||||||||||
| Investments: |
||||||||||||||||||||
| Fixed maturity securities: |
||||||||||||||||||||
| U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | $ | $ | |||||||||||||||
| State and political subdivisions |
||||||||||||||||||||
| Non-U.S. government |
||||||||||||||||||||
| U.S. corporate: |
||||||||||||||||||||
| Utilities |
||||||||||||||||||||
| Energy |
||||||||||||||||||||
| Finance and insurance |
||||||||||||||||||||
| Consumer—non-cyclical |
||||||||||||||||||||
| Technology and communications |
||||||||||||||||||||
| Industrial |
||||||||||||||||||||
| Capital goods |
||||||||||||||||||||
| Consumer—cyclical |
||||||||||||||||||||
| Transportation |
||||||||||||||||||||
| Other |
||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Total U.S. corporate |
||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Non-U.S. corporate: |
||||||||||||||||||||
| Utilities |
||||||||||||||||||||
| Energy |
||||||||||||||||||||
| Finance and insurance |
||||||||||||||||||||
| Consumer—non-cyclical |
||||||||||||||||||||
| Technology and communications |
||||||||||||||||||||
| Industrial |
||||||||||||||||||||
| Capital goods |
||||||||||||||||||||
| Consumer—cyclical |
||||||||||||||||||||
| Transportation |
||||||||||||||||||||
| Other |
||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Total non-U.S. corporate |
||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Residential mortgage-backed |
||||||||||||||||||||
| Commercial mortgage-backed |
||||||||||||||||||||
| Other asset-backed |
||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Total fixed maturity securities |
||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Equity securities |
||||||||||||||||||||
| Limited partnerships |
||||||||||||||||||||
| Other invested assets: |
||||||||||||||||||||
| Derivative assets: |
||||||||||||||||||||
| Interest rate swaps |
||||||||||||||||||||
| Foreign currency swaps |
||||||||||||||||||||
| Equity index options |
||||||||||||||||||||
| Forward bond purchase commitments |
||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Total derivative assets |
||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Short-term investments |
||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Total other invested assets |
||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Separate account assets |
||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Total assets |
$ | $ | $ | $ | $ | |||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
(1) |
Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. |
Beginning balance as of January 1, 2024 |
Total realized and unrealized gains (losses) |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 (1) |
Transfer out of Level 3 (1) |
Ending balance as of March 31, 2024 |
Total gains (losses) attributable to assets still held |
|||||||||||||||||||||||||||||||||||||||
| (Amounts in millions) |
Included in net income |
Included in OCI |
Included in net income |
Included in OCI |
||||||||||||||||||||||||||||||||||||||||||||
| Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||||||||||||||
| and subdivisions |
$ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||
| U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
| Utilities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
| Energy |
||||||||||||||||||||||||||||||||||||||||||||||||
| Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Consumer—non-cyclical |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| Technology and communications |
||||||||||||||||||||||||||||||||||||||||||||||||
| Industrial |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
| Transportation |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Total U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
| Utilities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
| Energy |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Technology and communications |
||||||||||||||||||||||||||||||||||||||||||||||||
| Industrial |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
| Capital goods |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| Consumer—cyclical |
||||||||||||||||||||||||||||||||||||||||||||||||
| Transportation |
||||||||||||||||||||||||||||||||||||||||||||||||
| Other |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Total non-U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Residential mortgage-backed |
||||||||||||||||||||||||||||||||||||||||||||||||
| Commercial mortgage-backed |
||||||||||||||||||||||||||||||||||||||||||||||||
| Other asset-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Total fixed maturity securities |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Equity securities |
||||||||||||||||||||||||||||||||||||||||||||||||
| Limited partnerships |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Other invested assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
| Equity index options |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| Forward bond purchase commitments |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Total derivative assets |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
| Short-term investments |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Total other invested assets |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Total Level 3 assets |
$ | $ | $ | ( |
) | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
(1) |
The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. |
| (Amounts in millions) |
Beginning balance as of January 1, 2023 |
Total realized and unrealized gains (losses) |
Transfer into Level 3 (1) |
Transfer out of Level 3 (1) |
Ending balance as of March 31, 2023 |
Total gains (losses) attributable to assets still held |
||||||||||||||||||||||||||||||||||||||||||
Included in net income |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Included in net income |
Included in OCI |
|||||||||||||||||||||||||||||||||||||||||
| securities: |
||||||||||||||||||||||||||||||||||||||||||||||||
| and subdivisions |
$ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||
| U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
| Utilities |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Energy |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Consumer—non-cyclical |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| Technology and communications |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| Industrial |
||||||||||||||||||||||||||||||||||||||||||||||||
| Capital goods |
||||||||||||||||||||||||||||||||||||||||||||||||
| Consumer—cyclical |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| Transportation |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| Other |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Total U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
| Utilities |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| Energy |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| Finance and insurance |
||||||||||||||||||||||||||||||||||||||||||||||||
| Consumer—non-cyclical |
||||||||||||||||||||||||||||||||||||||||||||||||
| Technology and communications |
||||||||||||||||||||||||||||||||||||||||||||||||
| Industrial |
||||||||||||||||||||||||||||||||||||||||||||||||
| Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Transportation |
||||||||||||||||||||||||||||||||||||||||||||||||
| Other |
||||||||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Total non-U.S. corporate |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Residential mortgage-backed |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| Commercial mortgage-backed |
||||||||||||||||||||||||||||||||||||||||||||||||
| Other asset-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Total fixed maturity securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Equity securities |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| Limited partnerships |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Other invested assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
| Equity index options |
||||||||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Total derivative assets |
||||||||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Total other invested assets |
||||||||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
| Total Level 3 assets |
$ | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
(1) |
The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. |
| (Amounts in millions) |
2024 |
2023 |
||||||
| Total realized and unrealized gains (losses) included in net income: |
||||||||
| |
$ | $ | ||||||
| |
( |
) | ||||||
| |
|
|
|
|||||
| |
$ | $ | ||||||
| |
|
|
|
|||||
| Net gains (losses) included in net income attributable to assets still held: |
||||||||
| |
$ | $ | ||||||
| |
( |
) | ||||||
| |
|
|
|
|||||
| |
$ | $ | ||||||
| |
|
|
|
|||||
(Amounts in millions) |
Fair value |
Unobservable input |
Range |
Weighted-average (1) | ||||||
Fixed maturity securities: |
||||||||||
U.S. corporate: |
||||||||||
Utilities |
$ | Credit spreads | ||||||||
Energy |
Credit spreads | |||||||||
Finance and insurance |
Credit spreads | |||||||||
Consumer—non-cyclical |
Credit spreads | |||||||||
Technology and communications |
Credit spreads | |||||||||
Industrial |
Credit spreads | |||||||||
Capital goods |
Credit spreads | |||||||||
Consumer—cyclical |
Credit spreads | |||||||||
Transportation |
Credit spreads | |||||||||
Other |
Credit spreads | |||||||||
Total U.S. corporate |
$ | Credit spreads | ||||||||
Non-U.S. corporate: |
||||||||||
Utilities |
$ | Credit spreads | ||||||||
Energy |
Credit spreads | |||||||||
Finance and insurance |
Credit spreads | |||||||||
Consumer—non-cyclical |
Credit spreads | |||||||||
Technology and communications |
Credit spreads | |||||||||
Industrial |
Credit spreads | |||||||||
Capital goods |
Credit spreads | |||||||||
Transportation |
Credit spreads | |||||||||
Other |
Credit spreads | |||||||||
Total non-U.S. corporate |
$ | Credit spreads | ||||||||
Derivative assets: |
||||||||||
Equity index options |
$ | Equity index volatility | ||||||||
Forward bond purchase commitments |
$ | Counterparty financing spreads | ||||||||
Other assets (2) |
$ | Lapse rate | ||||||||
| Non-performance risk | ||||||||||
| (counterparty credit risk) | ||||||||||
| Equity index volatility | ||||||||||
(1) |
Unobservable inputs weighted by the relative fair value of the associated instrument for fixed maturity securities, notional for derivative assets and the policyholder account balances associated with the instrument for the net reinsured portion of our variable annuity MRBs. |
(2) |
Represents the net reinsured portion of our variable annuity MRBs. |
March 31, 2024 |
||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Liabilities |
||||||||||||||||
Policyholder account balances: |
||||||||||||||||
Fixed indexed annuity embedded derivatives |
$ | $ | $ | $ | ||||||||||||
Indexed universal life embedded derivatives |
||||||||||||||||
Total policyholder account balances |
||||||||||||||||
Derivative liabilities: |
||||||||||||||||
Interest rate swaps |
||||||||||||||||
Foreign currency swaps |
||||||||||||||||
Forward bond purchase commitments |
||||||||||||||||
Total derivative liabilities |
||||||||||||||||
Total liabilities |
$ | $ | $ | $ | ||||||||||||
December 31, 2023 |
||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Liabilities |
||||||||||||||||
Policyholder account balances: |
||||||||||||||||
Fixed indexed annuity embedded derivatives |
$ | $ | $ | $ | ||||||||||||
Indexed universal life embedded derivatives |
||||||||||||||||
Total policyholder account balances |
||||||||||||||||
Derivative liabilities: |
||||||||||||||||
Interest rate swaps |
||||||||||||||||
Foreign currency swaps |
||||||||||||||||
Forward bond purchase commitments |
||||||||||||||||
Total derivative liabilities |
||||||||||||||||
Total liabilities |
$ | $ | $ | $ | ||||||||||||
Beginning balance as of January 1, 2024 |
Total realized and unrealized (gains) losses |
Ending balance as of March 31, 2024 |
Total (gains) losses attributable to liabilities still held |
|||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
Included in net (income) |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 |
Transfer out of Level 3 |
Included in net (income) |
Included in OCI |
||||||||||||||||||||||||||||||||||||||
Policyholder account balances: |
||||||||||||||||||||||||||||||||||||||||||||||||
Fixed indexed annuity embedded derivatives |
$ | $ | $ | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Total policyholder account balances |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Derivative liabilities: |
||||||||||||||||||||||||||||||||||||||||||||||||
Forward bond purchase commitments |
||||||||||||||||||||||||||||||||||||||||||||||||
Total derivative liabilities |
||||||||||||||||||||||||||||||||||||||||||||||||
Total Level 3 liabilities |
$ | $ | $ | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||||||||||||
Beginning balance as of January 1, 2023 |
Total realized and unrealized (gains) losses |
Ending balance as of March 31, 2023 |
Total (gains) losses attributable to liabilities still held |
|||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
Included in net (income) |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 |
Transfer out of Level 3 |
Included in net (income) |
Included in OCI |
||||||||||||||||||||||||||||||||||||||
Policyholder account balances: |
||||||||||||||||||||||||||||||||||||||||||||||||
Fixed indexed annuity embedded derivatives |
$ | $ | $ | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Total policyholder account balances |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Total Level 3 liabilities |
$ | $ | ( |
) | $ | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | ||||||||||||||||||||||||||||
(Amounts in millions) |
2024 |
2023 |
||||||
Total realized and unrealized (gains) losses included in net (income): |
||||||||
| $ | $ | |||||||
| ( |
) | |||||||
| $ | $ | ( |
) | |||||
Total (gains) losses included in net (income) attributable to liabilities still held: |
||||||||
| $ | $ | |||||||
| ( |
) | |||||||
| $ | $ | ( |
) | |||||
| (Amounts in millions) |
Fair value |
Unobservable input |
Range |
Weighted-average (1) |
||||||||
| Policyholder account balances: |
||||||||||||
| Fixed indexed annuity embedded derivatives |
$ | Expected future interest credited | ||||||||||
| Indexed universal life embedded derivatives |
$ | Expected future interest credited | ||||||||||
| Market risk benefits (2) : |
||||||||||||
| Fixed indexed annuities |
$ | GMWB utilization rate | % - |
|||||||||
| Non-performance risk (credit spreads) | ||||||||||||
| Expected future interest credited | ||||||||||||
| Variable annuities |
$ | Lapse rate | ||||||||||
| GMWB utilization rate | ||||||||||||
| Non-performance risk (credit spreads) | ||||||||||||
| Equity index volatility | ||||||||||||
| Derivative liabilities: |
||||||||||||
| Forward bond purchase commitments |
$ | Counterparty financing spreads | ||||||||||
(1) |
Unobservable inputs weighted by the policyholder account balances associated with the instrument and . notional for derivative liabilities |
(2) |
Refer to note 11 for additional details related to MRBs. |
March 31, 2024 |
||||||||||||||||||||||||
Notional amount |
Carrying amount |
Fair value |
||||||||||||||||||||||
| (Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||||||||||
| Assets: |
||||||||||||||||||||||||
| Commercial mortgage loans, net |
(1) |
$ | $ | $ | $ | $ | ||||||||||||||||||
| Bank loan investments |
(1) |
|||||||||||||||||||||||
| Liabilities: |
||||||||||||||||||||||||
| Long-term borrowings |
(1) |
|||||||||||||||||||||||
| Investment contracts |
(1) |
|||||||||||||||||||||||
| Commitments to fund investments: |
||||||||||||||||||||||||
| Bank loan investments |
$ | |||||||||||||||||||||||
| Private placement investments |
||||||||||||||||||||||||
| Commercial mortgage loans |
||||||||||||||||||||||||
(1) |
These financial instruments do not have notional amounts. |
December 31, 2023 |
||||||||||||||||||||||||
Notional amount |
Carrying amount |
Fair value |
||||||||||||||||||||||
| (Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||||||||||
| Assets: |
||||||||||||||||||||||||
| Commercial mortgage loans, net |
(1) |
$ | $ | $ | $ | $ | ||||||||||||||||||
| Bank loan investments |
(1) |
|||||||||||||||||||||||
| Liabilities: |
||||||||||||||||||||||||
| Long-term borrowings |
(1) |
|||||||||||||||||||||||
| Investment contracts |
(1) |
|||||||||||||||||||||||
| Commitments to fund investments: |
||||||||||||||||||||||||
| Bank loan investments |
$ | |||||||||||||||||||||||
| Private placement investments |
||||||||||||||||||||||||
| Commercial mortgage loans |
||||||||||||||||||||||||
(1) |
These financial instruments do not have notional amounts. |
March 31, 2024 |
December 31, 2023 |
|||||||||||||||
| (Amounts in millions) |
Carrying value |
Commitments to fund |
Carrying value |
Commitments to fund |
||||||||||||
| Limited partnerships accounted for at NAV: |
||||||||||||||||
| Private equity funds (1) |
$ | $ | $ | $ | ||||||||||||
| Real estate funds (2) |
||||||||||||||||
| Infrastructure funds (3) |
||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Total limited partnerships accounted for at NAV |
||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Limited partnerships accounted for at fair value |
||||||||||||||||
| Limited partnerships accounted for under equity method of accounting |
||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Total |
$ | $ | $ | $ | ||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
(1) |
This class employs various investment strategies such as leveraged buyout, growth equity, venture capital and mezzanine financing, generally investing in debt or equity positions directly in companies or assets of various sizes across diverse industries globally, primarily concentrated in North America. |
(2) |
This class invests in real estate in North America, Europe and Asia via direct property ownership, joint ventures, mortgages and investments in debt and equity instruments. |
(3) |
This class invests in the debt or equity of cash flow generating assets diversified across a variety of industries, including transportation, energy infrastructure, renewable power, social infrastructure, power generation, water, telecommunications and other regulated entities globally. |
March 31, 2024 |
||||||||||||||||||||
| (Amounts in millions) |
Long-term care insurance |
Life insurance |
Fixed annuities |
Variable annuities |
Total |
|||||||||||||||
| Balance as of January 1 |
$ | $ | $ | $ | $ | |||||||||||||||
| Costs deferred |
||||||||||||||||||||
| Amortization |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Balance as of March 31 |
$ | $ | $ | $ | ||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Enact segment |
||||||||||||||||||||
| |
|
|||||||||||||||||||
| Total deferred acquisition costs |
$ | |||||||||||||||||||
| |
|
|||||||||||||||||||
December 31, 2023 |
||||||||||||||||||||
| (Amounts in millions) |
Long-term care insurance |
Life insurance |
Fixed annuities |
Variable annuities |
Total |
|||||||||||||||
| Balance as of January 1 |
$ | $ | $ | $ | $ | |||||||||||||||
| Costs deferred |
||||||||||||||||||||
| Amortization |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Balance as of December 31 |
$ | $ | $ | $ | ||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Enact segment |
||||||||||||||||||||
| |
|
|||||||||||||||||||
| Total deferred acquisition costs |
$ | |||||||||||||||||||
| |
|
|||||||||||||||||||
| (Amounts in millions) |
March 31, 2024 |
December 31, 2023 |
||||||
| Long-term care insurance |
$ | $ | ||||||
| Life insurance |
||||||||
| Fixed annuities |
||||||||
| |
|
|
|
|||||
| Total long-duration insurance contracts |
||||||||
| |
|
|
|
|||||
| Deferred profit liability |
||||||||
| Cost of reinsurance |
||||||||
| |
|
|
|
|||||
| Total future policy benefits |
$ | $ | ||||||
| |
|
|
|
|||||
March 31, 2024 |
||||||||||||
(Dollar amounts in millions) |
Long-term care insurance |
Life insurance |
Fixed annuities |
|||||||||
Present value of expected net premiums: |
||||||||||||
Beginning balance as of January 1 |
$ | $ | $ | |||||||||
Beginning balance, at original discount rate |
$ | $ | $ | |||||||||
Effect of changes in cash flow assumptions |
||||||||||||
Effect of actual variances from expected experience |
( |
) | ( |
) | ||||||||
Adjusted beginning balance |
||||||||||||
Issuances |
||||||||||||
Interest accretion |
||||||||||||
Net premiums collected (1) |
( |
) | ( |
) | ( |
) | ||||||
Derecognition (lapses and withdrawals) |
||||||||||||
Other |
||||||||||||
Ending balance, at original discount rate |
||||||||||||
Effect of changes in discount rate assumptions |
( |
) | ||||||||||
Ending balance as of March 31 |
$ | $ | $ | |||||||||
Present value of expected future policy benefits: |
||||||||||||
Beginning balance as of January 1 |
$ | $ | $ | |||||||||
Beginning balance, at original discount rate |
$ | $ | $ | |||||||||
Effect of changes in cash flow assumptions |
( |
) | ||||||||||
Effect of actual variances from expected experience |
( |
) | ( |
) | ||||||||
Adjusted beginning balance |
||||||||||||
Issuances |
||||||||||||
Interest accretion |
||||||||||||
Benefit payments |
( |
) | ( |
) | ( |
) | ||||||
Derecognition (lapses and withdrawals) |
||||||||||||
Other |
||||||||||||
Ending balance, at original discount rate |
||||||||||||
Effect of changes in discount rate assumptions |
||||||||||||
Ending balance as of March 31 |
$ | $ | $ | |||||||||
Net liability for future policy benefits, before flooring adjustments |
$ | $ | $ | |||||||||
Flooring adjustments (2) |
||||||||||||
Net liability for future policy benefits |
||||||||||||
Less: reinsurance recoverable |
||||||||||||
Net liability for future policy benefits, net of reinsurance recoverable |
$ | $ | $ | |||||||||
Weighted-average liability duration (years) |
||||||||||||
(1) |
Represents the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. |
(2) |
Flooring adjustments are necessary when a cohort’s present value of future net premiums exceeds the present value of future benefits. The flooring adjustment ensures that the liability for future policy benefits for each cohort is not less than zero. This adjustment is most prevalent in our term life insurance products due to their product design of a level premium period followed by annual premium rate increases. |
December 31, 2023 |
||||||||||||
(Dollar amounts in millions) |
Long-term care insurance |
Life insurance |
Fixed annuities |
|||||||||
Present value of expected net premiums: |
||||||||||||
Beginning balance as of January 1 |
$ | $ | $ | |||||||||
Beginning balance, at original discount rate |
$ | $ | $ | |||||||||
Effect of changes in cash flow assumptions |
( |
) | ||||||||||
Effect of actual variances from expected experience |
( |
) | ||||||||||
Adjusted beginning balance |
||||||||||||
Issuances |
||||||||||||
Interest accretion |
||||||||||||
Net premiums collected (1) |
( |
) | ( |
) | ( |
) | ||||||
Derecognition (lapses and withdrawals) |
||||||||||||
Other |
||||||||||||
Ending balance, at original discount rate |
||||||||||||
Effect of changes in discount rate assumptions |
||||||||||||
Ending balance as of December 31 |
$ | $ | $ | |||||||||
Present value of expected future policy benefits: |
||||||||||||
Beginning balance as of January 1 |
$ | $ | $ | |||||||||
Beginning balance, at original discount rate |
$ | $ | $ | |||||||||
Effect of changes in cash flow assumptions |
( |
) | ( |
) | ||||||||
Effect of actual variances from expected experience |
( |
) | ( |
) | ||||||||
Adjusted beginning balance |
||||||||||||
Issuances |
||||||||||||
Interest accretion |
||||||||||||
Benefit payments |
( |
) | ( |
) | ( |
) | ||||||
Derecognition (lapses and withdrawals) |
||||||||||||
Other |
( |
) | ( |
) | ||||||||
Ending balance, at original discount rate |
||||||||||||
Effect of changes in discount rate assumptions |
||||||||||||
Ending balance as of December 31 |
$ | $ | $ | |||||||||
Net liability for future policy benefits, before flooring adjustments |
$ | $ | $ | |||||||||
Flooring adjustments (2) |
||||||||||||
Net liability for future policy benefits |
||||||||||||
Less: reinsurance recoverable |
||||||||||||
Net liability for future policy benefits, net of reinsurance recoverable |
$ | $ | $ | |||||||||
Weighted-average liability duration (years) |
||||||||||||
(1) |
Represents the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. |
(2) |
Flooring adjustments are necessary when a cohort’s present value of future net premiums exceeds the present value of future benefits. The flooring adjustment ensures that the liability for future policy benefits for each cohort is not less than zero. This adjustment is most prevalent in our term life insurance products due to their product design of a level premium period followed by annual premium rate increases. |
March 31, 2024 |
December 31, 2023 |
|||||||
Long-term care insurance |
||||||||
Interest accretion (locked-in) rate |
% | % | ||||||
Current discount rate |
% | % | ||||||
Life insurance |
||||||||
Interest accretion (locked-in) rate |
% | % | ||||||
Current discount rate |
% | % | ||||||
Fixed annuities |
||||||||
Interest accretion (locked-in) rate |
% | % | ||||||
Current discount rate |
% | % | ||||||
March 31, 2024 |
December 31, 2023 |
|||||||||||||||
(Amounts in millions) |
Undiscounted |
Discounted |
Undiscounted |
Discounted |
||||||||||||
Long-term care insurance |
||||||||||||||||
Expected future gross premiums |
$ | $ | $ | $ | ||||||||||||
Expected future benefit payments |
$ | $ | $ | $ | ||||||||||||
Life insurance |
||||||||||||||||
Expected future gross premiums |
$ | $ | $ | $ | ||||||||||||
Expected future benefit payments |
$ | $ | $ | $ | ||||||||||||
Fixed annuities |
||||||||||||||||
Expected future gross premiums |
$ | $ | $ | $ | ||||||||||||
Expected future benefit payments |
$ | $ | $ | $ | ||||||||||||
Three months ended March 31, |
||||||||||||||||||||||||
Year ended |
||||||||||||||||||||||||
2024 |
2023 |
December 31, 2023 |
||||||||||||||||||||||
| (Amounts in millions) |
Gross premiums |
Interest accretion (1) |
Gross premiums |
Interest accretion (1) |
Gross premiums |
Interest accretion (1) |
||||||||||||||||||
| Long-term care insurance |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Life insurance |
||||||||||||||||||||||||
| Fixed annuities |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
(1) |
Amounts for interest accretion are included in benefits and other changes in policy reserves in the condensed consolidated statements of income. |
| (Amounts in millions) |
March 31, 2024 |
December 31, 2023 |
||||||
| Life insurance |
$ | $ | ||||||
| Fixed annuities |
||||||||
| Variable annuities |
||||||||
| Fixed indexed annuity embedded derivatives (1) |
||||||||
| Indexed universal life embedded derivatives (1) |
||||||||
| Additional insurance liabilities (2) |
||||||||
| Other |
||||||||
| |
|
|
|
|||||
| Total policyholder account balances |
$ | $ | ||||||
| |
|
|
|
|||||
(1) |
See note 5 for additional information. |
(2) |
Represents additional liabilities related to death or other insurance benefits that are recorded within policyholder account balances and are considered long-duration insurance contracts. See note 10 for additional information. |
March 31, 2024 |
||||||||||||
| (Dollar amounts in millions) |
Life insurance |
Fixed annuities |
Variable annuities |
|||||||||
| Beginning balance as of January 1 |
$ | $ | $ | |||||||||
| Issuances |
||||||||||||
| Premiums received |
||||||||||||
| Policy charges |
( |
) | ( |
) | ( |
) | ||||||
| Surrenders and withdrawals |
( |
) | ( |
) | ( |
) | ||||||
| Benefit payments |
( |
) | ( |
) | ( |
) | ||||||
| Net transfers to separate accounts |
( |
) | ||||||||||
| Interest credited |
||||||||||||
| Other |
( |
) | ||||||||||
| |
|
|
|
|
|
|||||||
| Ending balance as of March 31 |
$ | $ | $ | |||||||||
| |
|
|
|
|
|
|||||||
| Weighted-average crediting rate |
% | % | % | |||||||||
| Net amount at risk (1) |
$ | $ | $ | |||||||||
| Cash surrender value |
$ | $ | $ | |||||||||
(1) |
The net amount at risk presented for fixed and variable annuity products contains both general and separate accounts, including amounts related to annuitization and other insurance benefits classified as MRBs. |
December 31, 2023 |
||||||||||||
| (Dollar amounts in millions) |
Life insurance |
Fixed annuities |
Variable annuities |
|||||||||
| Beginning balance as of January 1 |
$ | $ | $ | |||||||||
| Issuances |
||||||||||||
| Premiums received |
||||||||||||
| Policy charges |
( |
) | ( |
) | ( |
) | ||||||
| Surrenders and withdrawals |
( |
) | ( |
) | ( |
) | ||||||
| Benefit payments |
( |
) | ( |
) | ( |
) | ||||||
| Net transfers from separate accounts |
||||||||||||
| Interest credited |
||||||||||||
| Other |
( |
) | ||||||||||
| |
|
|
|
|
|
|||||||
| Ending balance as of December 31 |
$ | $ | $ | |||||||||
| |
|
|
|
|
|
|||||||
| Weighted-average crediting rate |
% | % | % | |||||||||
| Net amount at risk (1) |
$ | $ | $ | |||||||||
| Cash surrender value |
$ | $ | $ | |||||||||
(1) |
The net amount at risk presented for fixed and variable annuity products contains both general and separate accounts, including amounts related to annuitization and other insurance benefits classified as MRBs. |
March 31, 2024 |
||||||||||||||||||||
| (Amounts in millions) |
At guaranteed minimum |
points above |
points above |
Greater than points above |
Total (1) |
|||||||||||||||
| Less than |
$ | $ | $ | $ | $ | |||||||||||||||
| |
||||||||||||||||||||
| |
||||||||||||||||||||
| |
||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Total |
$ | $ | $ | $ | $ | |||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
(1) |
Excludes universal life insurance and investment contracts of approximately $ |
December 31, 2023 |
||||||||||||||||||||
| (Amounts in millions) |
At guaranteed minimum |
points above |
points above |
Greater than points above |
Total (1) |
|||||||||||||||
| Less than |
$ | $ | $ | $ | $ | |||||||||||||||
| |
||||||||||||||||||||
| |
||||||||||||||||||||
| |
||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Total |
$ | $ | $ | $ | $ | |||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
(1) |
Excludes universal life insurance and investment contracts of approximately $ |
| (Dollar amounts in millions) |
March 31, 2024 |
December 31, 2023 |
||||||
| Beginning balance as of January 1 |
$ | $ | ||||||
| Beginning balance before shadow accounting adjustments |
$ | $ | ||||||
| Effect of changes in cash flow assumptions |
||||||||
| Effect of actual variances from expected experience |
( |
) | ||||||
| |
|
|
|
|||||
| Adjusted beginning balance |
||||||||
| Issuances |
||||||||
| Interest accretion |
||||||||
| Assessments collected |
||||||||
| Benefit payments |
( |
) | ( |
) | ||||
| Derecognition (lapses and withdrawals) |
||||||||
| |
|
|
|
|||||
| Ending balance before shadow accounting adjustments |
||||||||
| Effect of shadow accounting adjustments |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Ending balance |
||||||||
| Less: reinsurance recoverable |
||||||||
| |
|
|
|
|||||
| Additional insurance liabilities, net of reinsurance recoverable |
$ | $ | ||||||
| |
|
|
|
|||||
| Weighted-average liability duration (years) |
||||||||
March 31, 2024 |
December 31, 2023 |
|||||||
| Interest accretion rate (1) |
% | % | ||||||
| Projected crediting rate (2) |
% | % | ||||||
(1) |
The interest accretion rate is determined by using the weighted-average policyholder crediting rates for the underlying policies over the period in-force, and based on the adjusted beginning balance, is used to measure the amount of interest accretion. |
(2) |
The projected crediting rate is determined by using a future crediting rate curve that utilizes a portfolio approach reflecting anticipated reinvestment activity and runoff of existing assets over the projection period. The projected crediting rate is used to discount future assessments and excess benefits. |
Three months ended |
Year ended December 31, |
|||||||||||
March 31, |
||||||||||||
| (Amounts in millions) |
2024 |
2023 |
2023 |
|||||||||
| Gross assessments |
$ | $ | $ | |||||||||
| Interest accretion (1) |
$ | $ | $ | |||||||||
(1) |
Amounts for interest accretion are included in benefits and other changes in policy reserves in the condensed consolidated statements of income. |
March 31, 2024 |
December 31, 2023 |
|||||||||||||||||||||||
| (Amounts in millions) |
Asset |
Liability |
Net liability |
Asset |
Liability |
Net liability |
||||||||||||||||||
| Fixed indexed annuities |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Variable annuities |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total market risk benefits |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
March 31, 2024 |
||||||||||||
| (Dollar amounts in millions) |
Fixed indexed annuities |
Variable annuities |
Reinsurance recoverable (1) |
|||||||||
| Beginning balance as of January 1 |
$ | $ | $ | |||||||||
| Beginning balance before effect of changes in instrument-specific credit risk |
$ | $ | $ | |||||||||
| Issuances |
||||||||||||
| Interest accretion |
||||||||||||
| Attributed fees collected |
||||||||||||
| Benefit payments |
( |
) | ( |
) | ||||||||
| Effect of changes in interest rates |
( |
) | ( |
) | ( |
) | ||||||
| Effect of changes in equity markets |
( |
) | ( |
) | ( |
) | ||||||
| Actual policyholder behavior different from expected behavior |
( |
) | ||||||||||
| Effect of changes in future expected policyholder behavior |
||||||||||||
| Effect of changes in other future expected assumptions |
||||||||||||
| Other |
||||||||||||
| |
|
|
|
|
|
|||||||
| Ending balance before effect of changes in instrument-specific credit risk |
||||||||||||
| Effect of changes in instrument-specific credit risk |
||||||||||||
| |
|
|
|
|
|
|||||||
| Ending balance as of March 31 |
$ | |||||||||||
| |
|
|||||||||||
| Less: reinsurance recoverable |
||||||||||||
| |
|
|
|
|||||||||
| Market risk benefits, net of reinsurance recoverable |
$ | $ | ||||||||||
| |
|
|
|
|||||||||
| Weighted-average attained age of contractholders |
||||||||||||
| Net amount at risk (2) |
||||||||||||
(1) |
Represents the net reinsured asset related to our variable annuity MRBs. |
(2) |
See note 9 for additional information on the net amount at risk. |
December 31, 2023 |
||||||||||||
| (Dollar amounts in millions) |
Fixed indexed annuities |
Variable annuities |
Reinsurance recoverable (1) |
|||||||||
| Beginning balance as of January 1 |
$ | $ | $ | |||||||||
| Beginning balance before effect of changes in instrument-specific credit risk |
$ | $ | $ | |||||||||
| Issuances |
||||||||||||
| Interest accretion |
||||||||||||
| Attributed fees collected |
||||||||||||
| Benefit payments |
( |
) | ( |
) | ||||||||
| Effect of changes in interest rates |
( |
) | ( |
) | ( |
) | ||||||
| Effect of changes in equity markets |
( |
) | ( |
) | ( |
) | ||||||
| Actual policyholder behavior different from expected behavior |
( |
) | ||||||||||
| Effect of changes in future expected policyholder behavior |
||||||||||||
| Effect of changes in other future expected assumptions |
||||||||||||
| Other |
( |
) | ||||||||||
| |
|
|
|
|
|
|||||||
| Ending balance before effect of changes in instrument-specific credit risk |
||||||||||||
| Effect of changes in instrument-specific credit risk |
||||||||||||
| |
|
|
|
|
|
|||||||
| Ending balance as of December 31 |
$ | |||||||||||
| |
|
|||||||||||
| Less: reinsurance recoverable |
||||||||||||
| |
|
|
|
|||||||||
| Market risk benefits, net of reinsurance recoverable |
$ | $ | ||||||||||
| |
|
|
|
|||||||||
| Weighted-average attained age of contractholders |
||||||||||||
| Net amount at risk (2) |
||||||||||||
(1) |
Represents the net reinsured asset related to our variable annuity MRBs. |
(2) |
See note 9 for additional information on the net amount at risk. |
| (Amounts in millions) |
March 31, 2024 |
December 31, 2023 |
||||||
| Beginning balance as of January 1 |
$ | $ | ||||||
| Premiums and deposits |
||||||||
| Policy charges |
( |
) | ( |
) | ||||
| Surrenders and withdrawals |
( |
) | ( |
) | ||||
| Benefit payments |
( |
) | ( |
) | ||||
| Investment performance |
||||||||
| Net transfers from (to) general account |
( |
) | ||||||
| Other charges |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Ending balance |
$ | $ | ||||||
| |
|
|
|
|||||
| Cash surrender value (1) |
$ | $ | ||||||
(1) |
Cash surrender value represents the amount of the contractholders’ account balances that was distributable less certain surrender charges. |
| (Amounts in millions) |
March 31, 2024 |
December 31, 2023 |
||||||
| Equity funds |
$ | $ | ||||||
| Balanced funds |
||||||||
| Bond funds |
||||||||
| Money market funds |
||||||||
| |
|
|
|
|||||
| Total |
$ | $ | ||||||
| |
|
|
|
|||||
| (Amounts in millions) |
March 31, 2024 |
December 31, 2023 |
||||||
| Enact segment |
$ | $ | ||||||
| Life and Annuities segment (1) |
||||||||
| Other mortgage insurance business |
||||||||
| |
|
|
|
|||||
| Total liability for policy and contract claims |
$ | $ | ||||||
| |
|
|
|
|||||
(1) |
Primarily includes balances related to our universal and term universal life insurance products. |
Three months ended March 31, |
||||||||
| (Amounts in millions) |
2024 |
2023 |
||||||
| Beginning balance as of January 1 |
$ | $ | ||||||
| Less reinsurance recoverable |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Net beginning balance |
||||||||
| |
|
|
|
|||||
| Incurred related to insured events of: |
||||||||
| Current year |
||||||||
| Prior years |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Total incurred |
||||||||
| |
|
|
|
|||||
| Paid related to insured events of: |
||||||||
| Current year |
( |
) | ( |
) | ||||
| Prior years |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Total paid |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Foreign currency translation |
||||||||
| |
|
|
|
|||||
| Net ending balance |
||||||||
| Add reinsurance recoverable |
||||||||
| |
|
|
|
|||||
| Ending balance as of March 31 |
$ | $ | ||||||
| |
|
|
|
|||||
Three months ended March 31, |
||||||||
2024 |
2023 |
|||||||
Statutory U.S. federal income tax rate |
% | % | ||||||
Increase in rate resulting from: |
||||||||
Tax on income from terminated swaps |
||||||||
Non-deductible expenses |
||||||||
Other, net |
( |
) | ||||||
Effective rate |
% | % | ||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2024 |
2023 |
||||||
Revenues: |
||||||||
Enact segment |
$ | $ | ||||||
Long-Term Care Insurance segment |
||||||||
Life and Annuities segment: |
||||||||
Life insurance |
||||||||
Fixed annuities |
||||||||
Variable annuities |
||||||||
Life and Annuities segment |
||||||||
Corporate and Other |
( |
) | ||||||
Total revenues |
$ | $ | ||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2024 |
2023 |
||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
Add: net income attributable to noncontrolling interests |
||||||||
Net income |
||||||||
Less: loss from discontinued operations, net of taxes |
( |
) | ||||||
Income from continuing operations |
||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
||||||||
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: |
||||||||
Net investment (gains) losses, net (1) |
( |
) | ||||||
Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges (2) |
( |
) | ||||||
(Gains) losses on early extinguishment of debt |
( |
) | ( |
) | ||||
Expenses related to restructuring |
||||||||
Taxes on adjustments |
( |
) | ||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
(1) |
For the three months ended March 31, 2024, net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $ |
(2) |
Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $( |
Three months ended March 31, |
||||||||
(Amounts in millions) |
2024 |
2023 |
||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||
Enact segment |
$ | $ | ||||||
Long-Term Care Insurance segment |
||||||||
Life and Annuities segment: |
||||||||
Life insurance |
( |
) | ( |
) | ||||
Fixed annuities |
||||||||
Variable annuities |
||||||||
Life and Annuities segment |
( |
) | ( |
) | ||||
Corporate and Other |
( |
) | ( |
) | ||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
March 31, |
December 31, |
|||||||
(Amounts in millions) |
2024 |
2023 |
||||||
Assets: |
||||||||
Enact segment |
$ | $ | ||||||
Long-Term Care Insurance segment |
||||||||
Life and Annuities segment |
||||||||
Corporate and Other |
||||||||
Total assets |
$ | $ | ||||||
| (Amounts in millions) |
Net unrealized investment gains (losses) |
Derivatives qualifying as hedges (1) |
Change in the discount rate used to measure future policy benefits |
Change in instrument- specific credit risk of market risk benefits |
Foreign currency translation and other adjustments |
Total |
||||||||||||||||||
| Balances as of January 1, 2024 |
$ | ( |
) | $ | $ | ( |
) | $ | ( |
) | $ | $ | ( |
) | ||||||||||
| OCI before reclassifications |
( |
) | ( |
) | ||||||||||||||||||||
| Amounts reclassified from OCI |
( |
) | ( |
) | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Current period OCI |
( |
) | ( |
) | ||||||||||||||||||||
| Balances as of March 31, 2024 before noncontrolling interests |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Less: change in OCI attributable to noncontrolling interests |
( |
) | ( |
) | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Balances as of March 31, 2024 |
$ | ( |
) | $ | $ | ( |
) | $ | ( |
) | $ | $ | ( |
) | ||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
(1) |
See note 5 for additional information. |
| (Amounts in millions) |
Net unrealized investment gains (losses) |
Derivatives qualifying as hedges (1) |
Change in the discount rate used to measure future policy benefits |
Change in instrument- specific credit risk of market risk benefits |
Foreign currency translation and other adjustments |
Total |
||||||||||||||||||
| Balances as of January 1, 2023 |
$ | ( |
) | $ | $ | ( |
) | $ | ( |
) | $ | $ | ( |
) | ||||||||||
| OCI before reclassifications |
( |
) | ( |
) | ||||||||||||||||||||
| Amounts reclassified from OCI |
( |
) | ( |
) | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Current period OCI |
( |
) | ( |
) | ||||||||||||||||||||
| Balances as of March 31, 2023 before noncontrolling interests |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Less: change in OCI attributable to noncontrolling interests |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Balances as of March 31, 2023 |
$ | ( |
) | $ | $ | ( |
) | $ | ( |
) | $ | $ | ( |
) | ||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
(1) |
See note 5 for additional information. |
Three months ended March 31, |
Affected line item in the condensed consolidated statements of income | |||||||||
| (Amounts in millions) |
2024 |
2023 |
||||||||
| Net unrealized investment (gains) losses: |
||||||||||
| Unrealized (gains) losses on investments |
$ | $ | Net investment (gains) losses | |||||||
| Income taxes |
( |
) | ( |
) | Provision for income taxes | |||||
| |
|
|
|
|||||||
| Total |
$ | $ | ||||||||
| |
|
|
|
|||||||
| Derivatives qualifying as hedges: |
||||||||||
| Interest rate swaps hedging assets |
$ | ( |
) | $ | ( |
) | Net investment income | |||
| Interest rate swaps hedging assets |
( |
) | ( |
) | Net investment (gains) losses | |||||
| Interest rate swaps hedging liabilities |
Interest expense | |||||||||
| Interest rate swaps hedging liabilities |
( |
) | Net investment (gains) losses | |||||||
| Foreign currency swaps |
( |
) | Net investment (gains) losses | |||||||
| Income taxes |
Provision for income taxes | |||||||||
| |
|
|
|
|||||||
| Total |
$ | ( |
) | $ | ( |
) | ||||
| |
|
|
|
|||||||
Table of Contents
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included herein and with our 2023 Annual Report on Form 10-K. Unless the context otherwise requires, references to “Genworth,” the “Company,” “we” or “our” herein are to Genworth Financial, Inc. on a consolidated basis. References to “Genworth Financial” refer solely to Genworth Financial, Inc., and not to any of its consolidated subsidiaries.
Cautionary note regarding forward-looking statements
This report contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “expects,” “intends,” “anticipates,” “plans,” “believes,” “seeks,” “estimates,” “will” or words of similar meaning and include, but are not limited to, statements regarding the outlook for our future business and financial performance. Examples of forward-looking statements include statements we make relating to potential dividends or share repurchases; future return of capital by Enact Holdings, Inc. (“Enact Holdings”), including share repurchases, and quarterly and special dividends; refinancing Enact Holdings’ debt maturities through debt offerings or other capital transactions; the cumulative economic benefit of approved and future rate actions contemplated in our long-term care insurance multi-year in-force rate action plan; future financial performance, including the expectation that adverse quarterly variances between actual and expected experience could persist resulting in future remeasurement losses in our long-term care insurance business; future financial condition of our businesses; liquidity and new lines of business or new products and services, such as those we are pursuing with our CareScout business (“CareScout”); as well as statements we make regarding the potential occurrence of a recession.
Forward-looking statements are based on management’s current expectations and assumptions, which are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Actual outcomes and results may differ materially from those in the forward-looking statements due to global political, economic, inflation, business, competitive, market, regulatory and other factors and risks, including but not limited to, the following:
| • | the inability to successfully launch new lines of business, including long-term care insurance and other products and services we are pursuing with CareScout; |
| • | our failure to maintain self-sustainability of our legacy life insurance subsidiaries, including as a result of the inability to achieve desired levels of in-force rate actions and/or the timing of future premium rate increases and associated benefit reductions taking longer to achieve than originally assumed; other regulatory actions negatively impacting our life insurance businesses; |
| • | inaccuracies or changes in estimates, assumptions, methodologies, valuations, projections and/or models, which result in inadequate reserves or other adverse results (including as a result of any changes in connection with quarterly, annual or other reviews); |
| • | the impact on holding company liquidity caused by an inability to receive dividends or any other returns of capital from Enact Holdings, and limited sources of capital and financing and the need to seek additional capital on unfavorable terms; |
| • | adverse changes to the structure or requirements of Federal National Mortgage Association (“Fannie Mae”), Federal Home Loan Mortgage Corporation (“Freddie Mac”) or the U.S. mortgage insurance market; an increase in the number of loans insured through federal government mortgage insurance programs, including those offered by the Federal Housing Administration (“FHA”); the inability of Enact Holdings and/or its U.S. mortgage insurance subsidiaries to continue to meet the requirements mandated by the private mortgage insurer eligibility requirements (“PMIERs”) (or any adverse changes thereto), inability to meet minimum statutory capital requirements of applicable regulators or the mortgage insurer eligibility requirements of Fannie Mae or Freddie Mac; |
72
Table of Contents
| • | changes in economic, market and political conditions including as a result of elevated inflation, labor shortages and elevated interest rates, which could heighten the risk of a future recession; unanticipated financial events, which could lead to market-wide liquidity problems and other significant market disruption resulting in losses, defaults or credit rating downgrades of other financial institutions; deterioration in economic conditions, a recession or a decline in home prices, all of which could be driven by many potential factors; political and economic instability or changes in government policies, and fluctuations in international securities markets; |
| • | downgrades in financial strength and credit ratings and potential adverse impacts to liquidity; counterparty credit risks; defaults by counterparties to reinsurance arrangements or derivative instruments; defaults or other events impacting the value of invested assets; |
| • | changes in tax rates or tax laws, or changes in accounting and reporting standards; |
| • | litigation and regulatory investigations or other actions, including commercial and contractual disputes with counterparties; |
| • | the inability to retain, attract and motivate qualified employees or senior management; |
| • | the loss of significant key customers and distribution relationships by Enact Holdings; |
| • | the impact from deficiencies in our disclosure controls and procedures or internal control over financial reporting; |
| • | the occurrence of natural or man-made disasters, including geopolitical tensions and war (including the Russian invasion of Ukraine and the Israel-Hamas conflict), a public health emergency, including pandemics, or climate change; |
| • | the inability to effectively manage information technology systems (including artificial intelligence), cyber incidents or other failures, disruptions or security breaches of us or our third-party vendors, as well as unknown risks and uncertainties associated with artificial intelligence; |
| • | the inability of third-party vendors to meet their obligations to us; |
| • | the lack of availability, affordability or adequacy of reinsurance to protect us against losses; |
| • | a decrease in the volume of high loan-to-value home mortgage originations or an increase in the volume of mortgage insurance cancellations; |
| • | unanticipated claims against Enact Holdings’ delegated underwriting program; |
| • | the impact of medical advances such as genetic research and diagnostic imaging, emerging new technology, including artificial intelligence and related legislation; and |
| • | other factors described in the risk factors contained in Item 1A of our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (“SEC”) on February 29, 2024. |
We provide additional information regarding these risks and uncertainties in our Annual Report on Form 10-K. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Accordingly, for the foregoing reasons, we caution you against relying on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required under applicable securities laws.
Overview
Genworth Financial, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial’s principal U.S. life insurance subsidiaries offer long-term care insurance and also manage in-force blocks of life insurance and annuity products. Genworth Financial also has a start-up business whereby it offers fee-based services, advice, consulting and other products and services through CareScout.
73
Table of Contents
We report our business results through three operating segments: Enact; Long-Term Care Insurance; and Life and Annuities. The products in the Life and Annuities segment include traditional and non-traditional life insurance (term, universal and term universal life insurance as well as corporate-owned life insurance and funding agreements), and fixed and variable annuities, none of which are actively marketed or sold.
In addition to our three operating segments, we also have Corporate and Other, which includes debt financing expenses that are incurred at the Genworth Holdings, Inc. (“Genworth Holdings”) level, unallocated corporate income and expenses, eliminations of inter-segment transactions and the results of other businesses that are reported outside of our operating segments, such as certain international businesses and CareScout start-up results related to our senior care growth initiatives.
Enact Holdings is a public company traded on the Nasdaq Global Select Market exchange under the ticker symbol “ACT.” Genworth Financial maintains control of Enact Holdings through an indirect majority voting interest and accordingly, Enact Holdings remains a consolidated subsidiary of Genworth Financial. Enact Holdings and its mortgage insurance subsidiaries comprise, and can therefore generally be viewed as, our Enact segment, or commonly referred to as “Enact.”
Strategic Update
We continue to further strengthen the financial and operational capabilities of our legacy long-term care insurance business primarily through our multi-year in-force rate action plan, achieving an estimated cumulative economic benefit of approximately $28.3 billion, on a net present value basis, of approved rate actions since 2012 through the first quarter of 2024. We manage our U.S. life insurance subsidiaries on a standalone basis. Accordingly, the U.S. life insurance subsidiaries will continue to rely on their statutory capital, significant reserves, prudent management of the in-force blocks and long-term care insurance in-force rate actions to satisfy policyholder obligations. For additional information regarding our in-force rate actions, see “—Results of Operations and Selected Financial and Operating Performance Measures by Segment” and “—Long-Term Care Insurance segment.”
We continue to make progress on our strategic priority to develop innovative aging services and solutions through our CareScout services business with the build-out of our network of long-term care providers (“CareScout Quality Network”), which is currently available in over 30 states. We plan to continue to add providers to the network that meet our quality credentialing standards and agree to negotiated preferred rates. While the initial focus has been with our long-term care insurance policyholders, we believe that over time and with national coverage of the CareScout Quality Network, we can expand the scope of our CareScout services business to additional consumer markets. In addition to the benefits to consumers, the discounts available through the network are expected to potentially further mitigate risk in our legacy long-term care insurance block by reducing claims costs. We aim to prudently scale and diversify our CareScout services business in a way that will leverage our intellectual property, drive claim savings in our legacy long-term care insurance block and drive long-term growth. We are also working to build the foundation necessary to re-enter the long-term care insurance market through our CareScout insurance business.
Enact continues to be a significant driver of value for Genworth, providing $61 million of capital returns to Genworth Holdings in the first quarter of 2024. We believe capital returns from Enact will continue to benefit our shareholders by funding our strategic initiatives, including new CareScout products and services, as well as share repurchases and opportunistic debt reduction. On May 1, 2024, Enact Holdings announced an increase of its next quarterly dividend to $0.185 per share to be paid in June 2024 and a new share repurchase authorization of $250 million. Since the initial authorization of Genworth Financial’s share repurchase program in May 2022 and through April 30, 2024, we have repurchased $434 million worth of shares of Genworth Financial’s common stock. For additional information on our share repurchase program, see “—Liquidity and Capital Resources.” We strive to maintain a disciplined approach in our capital allocation strategy, balancing investments in CareScout growth initiatives with returning value to shareholders.
74
Table of Contents
Financial Strength and Credit Ratings
On March 27, 2024, Moody’s Investors Service, Inc. affirmed the financial strength rating of “A3” of Enact Mortgage Insurance Corporation (“EMICO”) and changed the outlook to positive from stable. On April 12, 2024, Fitch Ratings, Inc. affirmed the financial strength rating of “A-” of EMICO and changed the outlook to positive from stable.
There were no other changes in the financial strength ratings of our insurance subsidiaries or the credit ratings of Genworth Financial and Genworth Holdings subsequent to February 29, 2024, the date we filed our 2023 Annual Report on Form 10-K. For additional information regarding the financial strength ratings of Genworth Financial’s insurance subsidiaries and the credit ratings of Genworth Financial and Genworth Holdings, including their importance to our business, see “Item 1—Ratings” in our 2023 Annual Report on Form 10-K.
Our Financial Information
The financial information in this Quarterly Report on Form 10-Q has been derived from our unaudited condensed consolidated financial statements.
Revenues and expenses
Our revenues consist primarily of the following:
| • | Premiums. Premiums consist primarily of premiums earned on insurance products for mortgage, long-term care and term life insurance. |
| • | Net investment income. Net investment income represents the income earned on our investments. For discussion of the change in net investment income, see the comparison for this line item under “—Investments and Derivative Instruments.” |
| • | Net investment gains (losses). Net investment gains (losses) consist primarily of realized gains and losses from the sale of our investments, credit losses, and unrealized gains and losses on equity securities, limited partnership investments and derivative instruments. For discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” |
| • | Policy fees and other income. Policy fees and other income consists primarily of fees assessed against policyholder and contractholder account values, surrender charges, cost of insurance assessed on universal and term universal life insurance policies, advisory and administration service fees assessed on investment contractholder account values, broker/dealer commission revenues, fee revenue from contract underwriting services and other fees. |
Our expenses consist primarily of the following:
| • | Benefits and other changes in policy reserves. Benefits and other changes in policy reserves consist primarily of benefits paid, interest accretion expense and other reserve activity related to future policy benefits for long-term care insurance, life insurance, and fixed and variable annuities, and claim costs incurred related to mortgage insurance products. |
| • | Liability remeasurement (gains) losses. Liability remeasurement (gains) losses represent changes to the net premium ratio for actual versus expected experience and updates to cash flow assumptions used to measure long-duration traditional and limited-payment insurance contracts. |
| • | Changes in fair value of market risk benefits and associated hedges. Changes in fair value of market risk benefits and associated hedges consist of fair value changes of market risk benefits (other than changes attributable to instrument-specific credit risk), net of changes in the fair value of non-qualified derivative instruments that support our market risk benefits. |
75
Table of Contents
| • | Interest credited. Interest credited represents interest credited on behalf of policyholder and contractholder general account balances. |
| • | Acquisition and operating expenses, net of deferrals. Acquisition and operating expenses, net of deferrals, represent costs and expenses related to the acquisition and ongoing maintenance of insurance and investment contracts, including commissions, policy issuance expenses and other underwriting and general operating costs. These costs and expenses are net of amounts that are capitalized and deferred, which are costs and expenses that are related directly to the successful acquisition of new or renewal insurance policies and investment contracts, such as first-year commissions in excess of ultimate renewal commissions and other policy issuance expenses. We allocate corporate expenses to each of our operating segments using various methodologies. |
| • | Amortization of deferred acquisition costs and intangibles. Amortization of deferred acquisition costs (“DAC”) and intangibles consists primarily of the amortization of capitalized acquisition costs, present value of future profits and capitalized software. |
| • | Interest expense. Interest expense primarily represents interest related to our borrowings that are incurred at Genworth Holdings or Enact Holdings. |
| • | Provision (benefit) for income taxes. We tax our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. generally accepted accounting principles (“U.S. GAAP”) and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other. |
The effective tax rates disclosed herein are calculated using whole numbers. As a result, the percentages shown may differ from an effective tax rate calculated using rounded numbers. The annually-determined tax rates and adjustments to each segment’s provision for income taxes are estimates which are subject to review and could change from year to year. For a discussion of the effective tax rates used to record the provision for income taxes for our three operating segments and Corporate and Other, see note 14 in our unaudited condensed consolidated financial statements under “Item 1—Financial Statements.”
| • | Net income attributable to noncontrolling interests. Net income attributable to noncontrolling interests represents third party ownership interests in income from continuing operations of a consolidated subsidiary. |
76
Table of Contents
Consolidated Results of Operations
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
The following table sets forth the consolidated results of operations for the periods indicated:
| Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
| (Amounts in millions) |
2024 | 2023 | 2024 vs. 2023 | |||||||||||||
| Revenues: |
||||||||||||||||
| Premiums |
$ | 875 | $ | 915 | $ | (40 | ) | (4 | )% | |||||||
| Net investment income |
782 | 787 | (5 | ) | (1 | )% | ||||||||||
| Net investment gains (losses) |
49 | (11 | ) | 60 | NM | (1) | ||||||||||
| Policy fees and other income |
158 | 163 | (5 | ) | (3 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Total revenues |
1,864 | 1,854 | 10 | 1 | % | |||||||||||
|
|
|
|
|
|
|
|||||||||||
| Benefits and expenses: |
||||||||||||||||
| Benefits and other changes in policy reserves |
1,203 | 1,176 | 27 | 2 | % | |||||||||||
| Liability remeasurement (gains) losses |
(8 | ) | (15 | ) | 7 | 47 | % | |||||||||
| Changes in fair value of market risk benefits and associated hedges |
(23 | ) | 17 | (40 | ) | NM | (1) | |||||||||
| Interest credited |
125 | 126 | (1 | ) | (1 | )% | ||||||||||
| Acquisition and operating expenses, net of deferrals |
236 | 240 | (4 | ) | (2 | )% | ||||||||||
| Amortization of deferred acquisition costs and intangibles |
65 | 72 | (7 | ) | (10 | )% | ||||||||||
| Interest expense |
30 | 29 | 1 | 3 | % | |||||||||||
|
|
|
|
|
|
|
|||||||||||
| Total benefits and expenses |
1,628 | 1,645 | (17 | ) | (1 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Income from continuing operations before income taxes |
236 | 209 | 27 | 13 | % | |||||||||||
| Provision for income taxes |
66 | 55 | 11 | 20 | % | |||||||||||
|
|
|
|
|
|
|
|||||||||||
| Income from continuing operations |
170 | 154 | 16 | 10 | % | |||||||||||
| Loss from discontinued operations, net of taxes |
(1 | ) | — | (1 | ) | NM | (1) | |||||||||
|
|
|
|
|
|
|
|||||||||||
| Net income |
169 | 154 | 15 | 10 | % | |||||||||||
| Less: net income attributable to noncontrolling interests |
30 | 32 | (2 | ) | (6 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Net income available to Genworth Financial, Inc.’s common stockholders |
$ | 139 | $ | 122 | $ | 17 | 14 | % | ||||||||
|
|
|
|
|
|
|
|||||||||||
| (1) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
Unless otherwise stated, all references to net income (loss), net income (loss) per share, adjusted operating income (loss) and adjusted operating income (loss) per share found in “Item 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read as net income (loss) available to Genworth Financial, Inc.’s common stockholders, net income (loss) available to Genworth Financial, Inc.’s common stockholders per share, adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders and adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders per share, respectively.
Use of non-GAAP measures
Reconciliation of net income (loss) to adjusted operating income (loss)
Management uses non-GAAP financial measures entitled “adjusted operating income (loss)” and “adjusted operating income (loss) per share” to evaluate performance and allocate resources. Adjusted operating income (loss) per share is derived from adjusted operating income (loss). We define adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items. A component of our net investment gains
77
Table of Contents
(losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. We exclude net investment gains (losses), changes in fair value of market risk benefits and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items from adjusted operating income (loss) because, in our opinion, they are not indicative of overall operating performance.
While some of these items may be significant components of net income (loss) determined in accordance with U.S. GAAP, we believe that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), including adjusted operating income (loss) per share on a basic and diluted basis, are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses adjusted operating income (loss), among other key performance indicators, as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from adjusted operating income (loss) have occurred in the past and could, and in some cases will, recur in the future. Adjusted operating income (loss) and adjusted operating income (loss) per share on a basic and diluted basis are not substitutes for net income (loss) or net income (loss) per share on a basic and diluted basis determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) may differ from the definitions used by other companies.
Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% tax rate and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments.
The following table presents a reconciliation of net income to adjusted operating income for the periods indicated:
| Three months ended March 31, |
||||||||
| (Amounts in millions) |
2024 | 2023 | ||||||
| Net income available to Genworth Financial, Inc.’s common stockholders |
$ | 139 | $ | 122 | ||||
| Add: net income attributable to noncontrolling interests |
30 | 32 | ||||||
|
|
|
|
|
|||||
| Net income |
169 | 154 | ||||||
| Less: loss from discontinued operations, net of taxes |
(1 | ) | — | |||||
|
|
|
|
|
|||||
| Income from continuing operations |
170 | 154 | ||||||
| Less: net income from continuing operations attributable to noncontrolling interests |
30 | 32 | ||||||
|
|
|
|
|
|||||
| Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
140 | 122 | ||||||
| Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: |
||||||||
| Net investment (gains) losses, net (1) |
(50 | ) | 11 | |||||
| Changes in fair value of market risk benefits attributable to changes in interest rates, equity markets and associated hedges (2) |
(26 | ) | 14 | |||||
| (Gains) losses on early extinguishment of debt |
(1 | ) | (1 | ) | ||||
| Expenses related to restructuring |
7 | 3 | ||||||
| Taxes on adjustments |
15 | (5 | ) | |||||
|
|
|
|
|
|||||
| Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 85 | $ | 144 | ||||
|
|
|
|
|
|||||
| (1) | For the three months ended March 31, 2024, net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $1 million. |
| (2) | Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(3) million for both the three months ended March 31, 2024 and 2023. |
78
Table of Contents
There were no infrequent or unusual items excluded from adjusted operating income during the periods presented.
Earnings per share
The following table provides basic and diluted earnings per common share for the periods indicated:
| Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
| (Amounts in millions, except per share amounts) |
2024 | 2023 | 2024 vs. 2023 | |||||||||||||
| Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||||||||||
| Basic |
$ | 0.32 | $ | 0.25 | $ | 0.07 | 28 | % | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Diluted |
$ | 0.31 | $ | 0.24 | $ | 0.07 | 29 | % | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||||||||||
| Basic |
$ | 0.31 | $ | 0.25 | $ | 0.06 | 24 | % | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Diluted |
$ | 0.31 | $ | 0.24 | $ | 0.07 | 29 | % | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Adjusted operating income available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||||||||||
| Basic |
$ | 0.19 | $ | 0.29 | $ | (0.10 | ) | (34 | )% | |||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Diluted |
$ | 0.19 | $ | 0.29 | $ | (0.10 | ) | (34 | )% | |||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Weighted-average common shares outstanding: |
||||||||||||||||
| Basic |
443.0 | 492.3 | ||||||||||||||
|
|
|
|
|
|||||||||||||
| Diluted |
450.3 | 500.1 | ||||||||||||||
|
|
|
|
|
|||||||||||||
Diluted weighted-average common shares outstanding reflect the effects of potentially dilutive securities including performance stock units, restricted stock units and other equity-based awards.
The following table presents a summary of adjusted operating income (loss) for our segments and Corporate and Other for the periods indicated:
| Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
| (Amounts in millions) |
2024 | 2023 | 2024 vs. 2023 | |||||||||||||
| Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
| Enact segment |
$ | 135 | $ | 143 | $ | (8 | ) | (6 | )% | |||||||
| Long-Term Care Insurance segment |
3 | 23 | (20 | ) | (87 | )% | ||||||||||
| Life and Annuities segment: |
||||||||||||||||
| Life insurance |
(33 | ) | (27 | ) | (6 | ) | (22 | )% | ||||||||
| Fixed annuities |
11 | 14 | (3 | ) | (21 | )% | ||||||||||
| Variable annuities |
7 | 9 | (2 | ) | (22 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Life and Annuities segment |
(15 | ) | (4 | ) | (11 | ) | NM | (1) | ||||||||
|
|
|
|
|
|
|
|||||||||||
| Corporate and Other |
(38 | ) | (18 | ) | (20 | ) | (111 | )% | ||||||||
|
|
|
|
|
|
|
|||||||||||
| Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 85 | $ | 144 | $ | (59 | ) | (41 | )% | |||||||
|
|
|
|
|
|
|
|||||||||||
| (1) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
79
Table of Contents
Executive Summary of Consolidated Financial Results
Below is an executive summary of our condensed consolidated financial results for the periods indicated. Amounts within this “Executive Summary of Consolidated Financial Results” are net of taxes, unless otherwise indicated. After-tax amounts assume a tax rate of 21%.
For a discussion of selected financial information and detailed descriptions of operating performance measures, see “—Results of Operations and Selected Financial and Operating Performance Measures by Segment.”
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
| • | Net income for the three months ended March 31, 2024 and 2023 was $139 million and $122 million, respectively, and adjusted operating income was $85 million and $144 million, respectively. |
| • | Enact segment |
| • | Adjusted operating income decreased primarily attributable to a lower reserve release and higher new delinquencies, partially offset by higher net investment income and premiums in the current year. |
| • | Long-Term Care Insurance segment |
| • | Adjusted operating income decreased primarily driven by less favorable mortality and lower renewal premiums in the current year. |
| • | The prior year included an unfavorable cash flow assumption update related to implementation timing of our in-force rate action plan, as well as a legal settlement accrual that did not recur. |
| • | Life and Annuities segment |
| • | Life insurance: |
| • | The adjusted operating loss in our life insurance products increased primarily due to lower premiums and product charges reflecting the runoff of our in-force blocks, partially offset by less unfavorable mortality experience in the current year. |
| • | Fixed annuities: |
| • | Adjusted operating income in our fixed annuity products decreased mainly from lower net spreads primarily related to block runoff in the current year. |
| • | Corporate and Other |
| • | The adjusted operating loss increased primarily from timing of certain tax related items in the current year and higher expenses related to CareScout growth initiatives. |
Significant Developments and Strategic Highlights
Enact segment
| • | Mortgage insurance portfolio. Enact’s primary persistency rate of 85% continued to offset the decline in new insurance written, contributing to insurance in-force growth in the first quarter of 2024. New insurance written decreased 20% in the first quarter of 2024 compared to the first quarter of 2023 mostly from a smaller estimated mortgage insurance market and lower estimated market share. |
| • | Loss performance. Enact recorded a pre-tax reserve release of $54 million during the first quarter of 2024 primarily related to favorable cure performance on delinquencies from early 2023 and prior |
80
Table of Contents
| compared to a pre-tax reserve release of $70 million in the first quarter of 2023 primarily related to favorable cure performance on COVID-19 delinquencies from 2020 and 2021. New primary delinquencies in the first quarter of 2024 increased compared to the first quarter of 2023 primarily due to the aging of large, newer books of business. |
| • | PMIERs compliance. Enact’s PMIERs sufficiency ratio was 163% or $1,883 million above the PMIERs requirements as of March 31, 2024. |
| • | Capital returns. Genworth Holdings received $61 million of capital returns from Enact Holdings during the first quarter of 2024. On May 1, 2024, Enact Holdings announced an increase of its next quarterly dividend to $0.185 per share to be paid in June 2024 and a new share repurchase authorization of $250 million. |
Long-Term Care Insurance segment
| • | In-force rate actions. We estimate that the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan since 2012 through the first quarter of 2024 was approximately $28.3 billion, on a net present value basis, as described further below. |
| • | Claims. We expect higher paid claims in our long-term care insurance business as our blocks age, with peak claim years over a decade away. Paid claims on newer products continue to increase as policyholders approach peak claim age, while claims on our oldest products decline as those policyholders, on average, are past peak claim age. We also expect overall claim costs to continue to increase as the approximately 620,000 insured individuals in our two largest blocks, Choice I and Choice II, with average attained ages of 77 and 74, respectively, reach their peak claim years, approximately age 85. |
Capital of U.S. life insurance subsidiaries
| • | As of March 31, 2024 and December 31, 2023, the consolidated company action level risk-based capital ratio of our U.S. domiciled life insurance subsidiaries was approximately 314% and 303%, respectively. The increase was primarily attributable to earnings in our long-term care insurance business primarily driven by premium increases and benefit reductions from in-force rate actions and legal settlements, as well as the favorable impacts of seasonally high mortality. The increase was also attributable to earnings in our variable annuity products, including a benefit from the impact of equity market and interest rate performance. |
Genworth Financial share repurchase program
| • | Genworth Financial executed $63 million of share repurchases in the first quarter of 2024. |
Results of Operations and Selected Financial and Operating Performance Measures by Segment
Management’s discussion and analysis by segment contains selected operating performance measures including “new insurance written,” “insurance in-force” and “risk in-force,” which are commonly used in the insurance industry as measures of operating performance.
Management regularly monitors and reports new insurance written for our Enact segment as a measure of volume of new business generated in a period. We consider new insurance written to be a measure of our Enact segment’s operating performance because it represents a measure of new sales of mortgage insurance policies during a specified period, rather than a measure of revenues or profitability during that period. Management also regularly monitors and reports insurance in-force and risk in-force for our Enact segment. Insurance in-force is a
81
Table of Contents
measure of the aggregate unpaid principal balance as of the respective reporting date for loans insured by our U.S. mortgage insurance subsidiaries. Risk in-force is based on the coverage percentage applied to the estimated current outstanding loan balance. These metrics are presented on a direct basis and exclude reinsurance. We consider insurance in-force and risk in-force to be measures of our Enact segment’s operating performance because they represent measures of the size of its business at a specific date which will generate revenues and profits in a future period, rather than measures of its revenues or profitability during that period.
Management also regularly monitors and reports a loss ratio for our Enact segment, which is the ratio of benefits and other changes in policy reserves to net earned premiums. We consider the loss ratio to be a measure of underwriting performance and helps to enhance the understanding of the operating performance of our Enact segment.
Management regularly monitors and reports on in-force rate actions, including state filing approvals; impacted in-force premiums; weighted-average percentage rate increases approved; and gross incremental premiums approved in our Long-Term Care Insurance segment. We also estimate the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan on a net present value basis, discounted at our investment portfolio yield. This is defined as the net present value of historical and future expected premium increases and benefit reductions based on current assumptions as a result of rate increases approved on individual and group long-term care insurance policies. It also includes the net present value of reserve reductions related to legal settlements less cash payments made to policyholders who elect certain reduced benefit options in connection with the legal settlements, referred to as settlement payments. We monitor these selected operating performance measures for in-force rate actions to track our progress on ensuring the continued self-sustainability of our legacy life insurance subsidiaries over time. We consider these in-force rate action metrics to be measures of financial performance and help to enhance the understanding of the operating performance of our Long-Term Care Insurance segment.
These operating performance measures enable us to compare our operating performance across periods without regard to revenues or profitability related to policies or contracts sold in prior periods or from investments or other sources.
Enact segment
Trends and conditions
Results of our Enact segment are affected primarily by the following factors: competitor actions; unemployment or underemployment levels; other economic and housing market trends, including interest rates, home prices, the number of first-time homebuyers, and mortgage origination volume mix and practices; the size of the overall private mortgage insurance market and the effect of regulatory actions thereon; the levels and aging of mortgage delinquencies; the effect of seasonal variations; the inventory of unsold homes; loan modification and other servicing efforts; and litigation, among other items. References to “Enact” included herein “Item 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” are, unless the context otherwise requires, to our Enact segment.
Macroeconomic environment
During the first quarter of 2024, the U.S. economy faced uncertainty due to continued inflationary pressure, the geopolitical environment and lingering concerns around a possible recession. Mortgage origination activity remained slow during the first quarter of 2024 in response to elevated mortgage rates and sustained low housing supply. Over the past few years, housing affordability has deteriorated due to high interest rates and elevated home prices, only marginally offset by rising median family income, according to the National Association of Realtors Housing Affordability Index. National home prices rose modestly throughout 2023 but remained relatively flat during the first quarter of 2024, according to the Federal Housing Finance Agency (“FHFA”) Monthly Purchase-Only House Price Index.
82
Table of Contents
The unemployment rate was 3.8% in March 2024, compared to 3.7% in December 2023. As of March 31, 2024, the number of unemployed Americans was approximately 6.4 million, and the number of long term unemployed over 26 weeks was approximately 1.2 million.
Forbearance and loss mitigation programs
In response to COVID-19, borrowers were allowed extended forbearance options to temporarily suspend mortgage payments up to 18 months subject to certain limits. Extended forbearance timelines permitted through the Coronavirus Aid Relief and Economic Security Act and government-sponsored enterprises (“GSEs”) COVID-19 servicing-related policies were retired in 2023. Borrowers that meet general hardship and program guidelines continue to have access to standard forbearance policies as a loss mitigation option. In addition, in March 2023, the GSEs announced new loss mitigation programs that allow six-month payment deferrals for borrowers facing financial hardship.
Although it is difficult to predict the future level of reported forbearance and how many of the loans in a forbearance plan that remain current on their monthly mortgage payment will go delinquent, servicer reported forbearances have generally declined. As of March 31, 2024, approximately 1.1% or 10,479 of Enact’s active primary policies were reported in a forbearance plan, of which approximately 26% were reported as delinquent.
Regulatory developments
Private mortgage insurance market penetration and overall market size are affected in part by actions that impact housing or housing finance policy taken by the GSEs and the U.S. government, including but not limited to, the FHA and the FHFA. In the past, these actions have included announced changes, or potential changes, to underwriting standards, including changes to the GSEs’ automated underwriting systems, FHA pricing, GSE guaranty fees, loan limits and alternative products.
On October 24, 2022, the FHFA announced its validation and approval of certain credit score models for use by the GSEs and changed the required number of credit reports provided by lenders from all three nationwide consumer reporting agencies to only two. The validation of the new credit scores requires lenders to deliver both credit scores for each loan sold to the GSEs. In February 2024, the FHFA announced that it is targeting the fourth quarter of 2025 for implementation, which will require system and process updates.
Competitive environment
The U.S. private mortgage insurance industry is highly competitive. Enact Holdings’ market share is influenced by the execution of its go to market strategy, including but not limited to, pricing competitiveness relative to its peers and its selective participation in forward commitment transactions. Enact continues to manage the quality of new business through pricing and its underwriting guidelines, which are modified from time to time when circumstances warrant. The market and underwriting conditions, including the mortgage insurance pricing environment, are within Enact’s risk adjusted return appetite, enabling it to write new business at returns it views as attractive.
Mortgage insurance portfolio
New insurance written of $10.5 billion in the first quarter of 2024 decreased 20% compared to the first quarter of 2023 mostly due to a smaller estimated mortgage insurance market and lower estimated market share. Enact’s primary persistency rate was 85% during both the first quarters of 2024 and 2023. Elevated persistency, driven by a large percentage of Enact’s in-force policies with mortgage rates below current rates, continued to offset the decline in new insurance written, leading to an increase in primary insurance in-force of $0.7 billion as compared to December 31, 2023.
83
Table of Contents
Net earned premiums increased in the first quarter of 2024 compared to the first quarter of 2023 primarily driven by insurance in-force growth, partially offset by higher ceded premiums.
Loss experience
Enact’s loss ratio for the three months ended March 31, 2024 and 2023 was 8% and (5)%, respectively. Enact released reserves of $54 million during the first quarter of 2024 primarily related to delinquencies from early 2023 and prior as recent uncertainty in the economic environment has not negatively impacted cure performance to the extent initially expected. During the first quarter of 2023, Enact recorded a reserve release of $70 million largely related to favorable cure performance on COVID-19 delinquencies from 2020 and 2021.
The severity of loss on loans that go to claim may be negatively impacted by the extended forbearance and foreclosure timelines, the associated elevated expenses and the higher loan amount of the recent new delinquencies. These negative influences on loss severity could be mitigated in part by embedded home price appreciation. For loans insured on or after October 1, 2014, Enact’s mortgage insurance policies limit the number of months of unpaid interest and associated expenses that are included in the mortgage insurance claim amount to a maximum of 36 months.
New primary delinquencies in the first quarter of 2024 increased compared to the first quarter of 2023 primarily due to the aging of large, newer books of business. New primary delinquencies of 11,395 contributed $74 million of loss expense in the first quarter of 2024, while Enact incurred $58 million of losses from 9,599 new primary delinquencies in the first quarter of 2023. In determining the loss expense estimate, considerations were given to recent cure and claim experience and the prevailing and prospective economic conditions. Approximately 8% of Enact’s primary new delinquencies in the first quarter of 2024 were subject to a forbearance plan compared to 17% in the first quarter of 2023. Due to the declining number of new delinquencies in forbearance, Enact no longer differentiates the expected claim rates applied to new delinquencies in forbearance versus those not in forbearance.
Capital requirements and transactions
As of March 31, 2024, EMICO’s risk-to-capital ratio under North Carolina law and enforced by the North Carolina Department of Insurance (“NCDOI”), EMICO’s domestic insurance regulator, was approximately 11.2:1, compared with a risk-to-capital ratio of 11.6:1 as of December 31, 2023. EMICO’s risk-to-capital ratio remains below the NCDOI’s maximum risk-to-capital ratio of 25:1. North Carolina’s calculation of risk-to-capital excludes the risk in-force for delinquent loans given the established loss reserves against all delinquencies. EMICO’s ongoing risk-to-capital ratio will depend principally on the magnitude of future losses incurred by EMICO, the effectiveness of ongoing loss mitigation activities, new business volume and profitability, the impact of quota share reinsurance, the amount of policy lapses and the amount of additional capital that is generated or distributed by the business.
Under PMIERs, Enact is subject to operational and financial requirements that private mortgage insurers must meet in order to remain eligible to insure loans that are purchased by the GSEs. As of March 31, 2024, Enact had estimated available assets of $4,853 million against $2,970 million net required assets under PMIERs compared to available assets of $5,006 million against $3,119 million net required assets as of December 31, 2023. The sufficiency ratio as of March 31, 2024 was 163% or $1,883 million above the PMIERs requirements, compared to 161% or $1,887 million above the PMIERs requirements as of December 31, 2023. Enact’s PMIERs required assets as of March 31, 2024 and December 31, 2023 benefited from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain non-performing loans as defined under PMIERs. The application of the 0.30 multiplier to all eligible delinquencies provided $48 million and $73 million, respectively, of benefit to Enact’s March 31, 2024 and December 31, 2023 PMIERs required assets. These amounts are gross of any incremental reinsurance benefit from the elimination of the 0.30 multiplier.
84
Table of Contents
On January 3, 2024, Enact entered into a quota share reinsurance agreement under which it will cede approximately 21% of a portion of its new insurance written in the 2024 book year. On January 30, 2024, Enact executed an excess of loss reinsurance transaction which provides up to $255 million of reinsurance coverage on a portion of current and expected new insurance written for the 2024 book year, effective January 1, 2024. Enact’s third-party reinsurance transactions provided an aggregate of approximately $1,722 million and $1,714 million of PMIERs capital credit as of March 31, 2024 and December 31, 2023, respectively. Enact may execute future credit risk transfer transactions to maintain a prudent level of financial flexibility in excess of the PMIERs capital requirements in response to potential changes in performance and PMIERs requirements over time.
Capital returns
In March 2024, EMICO completed a distribution to Enact Holdings that supports its ability to pay a quarterly dividend. On May 1, 2024, Enact Holdings announced an increase of its next quarterly dividend from $0.16 to $0.185 per share to be paid in June 2024. Future dividend payments are subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial. In addition to Enact’s quarterly dividend program, Enact Holdings announced approval by its board of directors on August 1, 2023 of a share repurchase program which allows for the repurchase of up to an additional $100 million of its common stock, and on May 1, 2024, Enact Holdings announced a new share repurchase authorization of $250 million. Genworth Holdings has agreed to participate in share repurchases in order to maintain its overall ownership at approximately its current level. As the majority shareholder, Genworth Holdings received $61 million of capital returns from Enact Holdings during the first quarter of 2024 comprised of $21 million of quarterly dividends and $40 million of share repurchases.
Returning capital to shareholders, balanced with growth and risk management priorities, remains a priority for Enact Holdings as it looks to enhance shareholder value through time. Future return of capital will be shaped by Enact Holdings’ capital prioritization framework, including supporting its existing policyholders, growing its mortgage insurance business, funding attractive new business opportunities and returning capital to shareholders. Enact Holdings’ total return of capital will also be based on its view of the prevailing and prospective macroeconomic conditions, regulatory landscape and business performance.
85
Table of Contents
Segment results of operations
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
The following table sets forth the results of operations relating to our Enact segment for the periods indicated:
| Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
| (Amounts in millions) |
2024 | 2023 | 2024 vs. 2023 | |||||||||||||
| Revenues: |
||||||||||||||||
| Premiums |
$ | 241 | $ | 235 | $ | 6 | 3 | % | ||||||||
| Net investment income |
57 | 46 | 11 | 24 | % | |||||||||||
| Net investment gains (losses) |
(6 | ) | — | (6 | ) | NM | (1) | |||||||||
|
|
|
|
|
|
|
|||||||||||
| Total revenues |
292 | 281 | 11 | 4 | % | |||||||||||
|
|
|
|
|
|
|
|||||||||||
| Benefits and expenses: |
||||||||||||||||
| Benefits and other changes in policy reserves |
20 | (11 | ) | 31 | NM | (1) | ||||||||||
| Acquisition and operating expenses, net of deferrals |
51 | 52 | (1 | ) | (2 | )% | ||||||||||
| Amortization of deferred acquisition costs and intangibles |
2 | 3 | (1 | ) | (33 | )% | ||||||||||
| Interest expense |
13 | 13 | — | — | % | |||||||||||
|
|
|
|
|
|
|
|||||||||||
| Total benefits and expenses |
86 | 57 | 29 | 51 | % | |||||||||||
|
|
|
|
|
|
|
|||||||||||
| Income from continuing operations before income taxes |
206 | 224 | (18 | ) | (8 | )% | ||||||||||
| Provision for income taxes |
45 | 49 | (4 | ) | (8 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Income from continuing operations |
161 | 175 | (14 | ) | (8 | )% | ||||||||||
| Less: net income attributable to noncontrolling interests |
30 | 32 | (2 | ) | (6 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
131 | 143 | (12 | ) | (8 | )% | ||||||||||
| Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
| Net investment (gains) losses, net(2) |
5 | — | 5 | NM | (1) | |||||||||||
| Taxes on adjustments |
(1 | ) | — | (1 | ) | NM | (1) | |||||||||
|
|
|
|
|
|
|
|||||||||||
| Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 135 | $ | 143 | $ | (8 | ) | (6 | )% | |||||||
|
|
|
|
|
|
|
|||||||||||
| (1) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
| (2) | Net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $1 million for the three months ended March 31, 2024. |
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders
Adjusted operating income decreased primarily attributable to a lower reserve release and higher new delinquencies, partially offset by higher net investment income and premiums in the current year.
Revenues
Premiums increased mostly from higher insurance in-force, partially offset by higher ceded premiums in the current year.
Net investment income increased primarily from higher investment yields and higher average invested assets in the current year.
86
Table of Contents
For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”
Benefits and expenses
Benefits and other changes in policy reserves increased largely from a lower reserve release and higher new delinquencies in the current year. Enact released reserves of $54 million during the first quarter of 2024 primarily related to delinquencies from early 2023 and prior as recent uncertainty in the economic environment has not negatively impacted cure performance to the extent initially expected. During the first quarter of 2023, Enact recorded a reserve release of $70 million largely related to favorable cure performance on COVID-19 delinquencies from 2020 and 2021.
Provision for income taxes. The effective tax rate was 21.8% and 21.6% for the three months ended March 31, 2024 and 2023, respectively, generally consistent with the U.S. corporate federal income tax rate.
Enact selected operating performance measures
Primary Mortgage Insurance
Substantially all of Enact’s policies are primary mortgage insurance, which provides protection on individual loans at specified coverage percentages. Primary mortgage insurance is placed on individual loans at the time of origination and is typically delivered to Enact on a loan-by-loan basis. Primary mortgage insurance can also be delivered to Enact on an aggregated basis, whereby each mortgage in a given loan portfolio is insured in a single transaction after the point of origination.
Pool Mortgage Insurance
Pool mortgage insurance transactions provide coverage on a finite set of individual loans identified by the pool policy. Pool policies contain coverage percentages and provisions limiting the insurer’s obligation to pay claims until a threshold amount is reached (known as a “deductible”) or capping the insurer’s potential aggregate liability for claims payments (known as a “stop loss”) or a combination of both provisions. Pool mortgage insurance is typically used to provide additional credit enhancement for certain secondary market mortgage transactions.
The following table sets forth selected operating performance measures regarding Enact as of and for the dates indicated:
| Three months ended March 31, | Increase (decrease) and percentage change |
|||||||||||||||
| (Amounts in millions) |
2024 | 2023 | 2024 vs. 2023 | |||||||||||||
| Primary insurance in-force |
$ | 263,645 | $ | 252,516 | $ | 11,129 | 4 | % | ||||||||
| Risk in-force: |
||||||||||||||||
| Primary |
$ | 67,950 | $ | 64,106 | $ | 3,844 | 6 | % | ||||||||
| Pool |
67 | 76 | (9 | ) | (12 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Total risk in-force |
$ | 68,017 | $ | 64,182 | $ | 3,835 | 6 | % | ||||||||
|
|
|
|
|
|
|
|||||||||||
| New insurance written |
$ | 10,526 | $ | 13,154 | $ | (2,628 | ) | (20 | )% | |||||||
Primary insurance in-force and risk in-force
Primary insurance in-force increased mainly from new insurance written. In addition, primary persistency remained elevated largely as a result of suppressed refinancing activity in the current year due to a large percentage of in-force policies with mortgage rates below current rates. The primary persistency rate was 85% for both the three months ended March 31, 2024 and 2023. Total risk in-force increased largely from higher primary insurance in-force.
87
Table of Contents
New insurance written
New insurance written decreased principally from a smaller estimated mortgage insurance market and lower estimated market share in the current year.
Loss and expense ratios
The following table sets forth the loss and expense ratios for Enact for the dates indicated:
| Three months ended March 31, |
Increase (decrease) | |||||||||||
| 2024 | 2023 | 2024 vs. 2023 | ||||||||||
| Loss ratio |
8 | % | (5 | )% | 13 | % | ||||||
| Expense ratio |
22 | % | 23 | % | (1 | )% | ||||||
The loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums. The expense ratio is the ratio of general expenses to net earned premiums. Enact’s general expenses consist of acquisition and operating expenses, net of deferrals, and amortization of DAC and intangibles.
The loss ratio increased largely from a lower reserve release and higher new delinquencies in the current year, as discussed above.
The expense ratio decreased primarily driven by higher premiums in the current year.
88
Table of Contents
Mortgage insurance loan portfolio
The following table sets forth selected financial information regarding Enact’s loan portfolio as of March 31:
| (Amounts in millions) |
2024 | 2023 | ||||||
| Primary insurance in-force by loan-to-value ratio at origination: |
||||||||
| 95.01% and above |
$ | 46,259 | $ | 40,776 | ||||
| 90.01% to 95.00% |
109,566 | 105,336 | ||||||
| 85.01% to 90.00% |
78,214 | 73,756 | ||||||
| 85.00% and below |
29,606 | 32,648 | ||||||
|
|
|
|
|
|||||
| Total |
$ | 263,645 | $ | 252,516 | ||||
|
|
|
|
|
|||||
| Primary risk in-force by loan-to-value ratio at origination: |
||||||||
| 95.01% and above |
$ | 13,250 | $ | 11,545 | ||||
| 90.01% to 95.00% |
31,881 | 30,589 | ||||||
| 85.01% to 90.00% |
19,265 | 18,054 | ||||||
| 85.00% and below |
3,554 | 3,918 | ||||||
|
|
|
|
|
|||||
| Total |
$ | 67,950 | $ | 64,106 | ||||
|
|
|
|
|
|||||
| Primary insurance in-force by FICO(1) score at origination: |
||||||||
| Over 760 |
$ | 111,589 | $ | 104,635 | ||||
| 740-759 |
43,155 | 40,983 | ||||||
| 720-739 |
37,068 | 35,554 | ||||||
| 700-719 |
29,679 | 29,160 | ||||||
| 680-699 |
21,628 | 21,717 | ||||||
| 660-679(2) |
11,316 | 11,057 | ||||||
| 640-659 |
6,109 | 6,114 | ||||||
| 620-639 |
2,488 | 2,604 | ||||||
| <620 |
613 | 692 | ||||||
|
|
|
|
|
|||||
| Total |
$ | 263,645 | $ | 252,516 | ||||
|
|
|
|
|
|||||
| Primary risk in-force by FICO score at origination: |
||||||||
| Over 760 |
$ | 28,703 | $ | 26,480 | ||||
| 740-759 |
11,167 | 10,418 | ||||||
| 720-739 |
9,669 | 9,126 | ||||||
| 700-719 |
7,629 | 7,406 | ||||||
| 680-699 |
5,524 | 5,481 | ||||||
| 660-679(2) |
2,908 | 2,809 | ||||||
| 640-659 |
1,562 | 1,549 | ||||||
| 620-639 |
632 | 660 | ||||||
| <620 |
156 | 177 | ||||||
|
|
|
|
|
|||||
| Total |
$ | 67,950 | $ | 64,106 | ||||
|
|
|
|
|
|||||
| (1) | Fair Isaac Company. |
| (2) | Loans with unknown FICO scores are included in the 660-679 category. |
89
Table of Contents
Delinquent loans
The following table sets forth the number of loans insured, the number of delinquent loans and the delinquency rate for Enact’s loan portfolio as of the dates indicated:
| March 31, 2024 |
December 31, 2023 |
March 31, 2023 |
||||||||||
| Primary insurance: |
||||||||||||
| Insured loans in-force |
969,866 | 974,516 | 965,544 | |||||||||
| Delinquent loans |
19,492 | 20,432 | 18,633 | |||||||||
| Percentage of delinquent loans (delinquency rate) |
2.01 | % | 2.10 | % | 1.93 | % | ||||||
Delinquency rates decreased compared to December 31, 2023 primarily from a decrease in total delinquencies mostly driven by cures and paid claims outpacing new delinquencies.
The following tables set forth primary delinquencies, direct primary case reserves and risk in-force by aged missed payment status in Enact’s loan portfolio as of the dates indicated:
| March 31, 2024 | ||||||||||||||||
| (Dollar amounts in millions) |
Delinquencies | Direct primary case reserves (1) |
Risk in-force |
Reserves as % of risk in-force |
||||||||||||
| Payments in default: |
||||||||||||||||
| 3 payments or less |
9,506 | $ | 87 | $ | 600 | 14 | % | |||||||||
| 4 - 11 payments |
6,853 | 220 | 468 | 47 | % | |||||||||||
| 12 payments or more |
3,133 | 179 | 197 | 91 | % | |||||||||||
|
|
|
|
|
|
|
|||||||||||
| Total |
19,492 | $ | 486 | $ | 1,265 | 38 | % | |||||||||
|
|
|
|
|
|
|
|||||||||||
| December 31, 2023 | ||||||||||||||||
| (Dollar amounts in millions) |
Delinquencies | Direct primary case reserves (1) |
Risk in-force |
Reserves as % of risk in-force |
||||||||||||
| Payments in default: |
||||||||||||||||
| 3 payments or less |
10,166 | $ | 88 | $ | 629 | 14 | % | |||||||||
| 4 - 11 payments |
6,934 | 205 | 469 | 44 | % | |||||||||||
| 12 payments or more |
3,332 | 184 | 200 | 92 | % | |||||||||||
|
|
|
|
|
|
|
|||||||||||
| Total |
20,432 | $ | 477 | $ | 1,298 | 37 | % | |||||||||
|
|
|
|
|
|
|
|||||||||||
| (1) | Direct primary case reserves exclude loss adjustment expenses, pool, incurred but not reported (“IBNR”) and reinsurance reserves. |
Reserves as a percentage of risk in-force as of March 31, 2024 remained relatively consistent with December 31, 2023 as long-term delinquencies with higher reserves have continued to cure. The number of loans that are delinquent for 12 months or more has decreased since December 31, 2023 and is more in line with pre-COVID-19 levels. Due to continued forbearance options, foreclosure moratoriums and the uncertainty around the lack of progression through the foreclosure process, there is still uncertainty around the likelihood and timing of delinquencies going to claim.
90
Table of Contents
Primary insurance delinquency rates differ from region to region in the United States at any one time depending upon economic conditions and cyclical growth patterns. The tables below set forth the dispersion of direct primary case reserves and primary delinquency rates for the 10 largest states and the 10 largest Metropolitan Statistical Areas (“MSA”) or Metro Divisions (“MD”) by Enact’s primary risk in-force as of the dates indicated. Delinquency rates are shown by region based upon the location of the underlying property rather than the location of the lender.
| Percent of primary risk in-force as of March 31, 2024 |
Percent of direct primary case reserves as of March 31, 2024 (1) |
Delinquency rate as of | ||||||||||||||||||
| March 31, 2024 |
December 31, 2023 |
March 31, 2023 |
||||||||||||||||||
| By State: |
||||||||||||||||||||
| California |
13 | % | 12 | % | 2.15 | % | 2.22 | % | 1.99 | % | ||||||||||
| Texas |
9 | % | 8 | % | 2.08 | % | 2.22 | % | 1.92 | % | ||||||||||
| Florida (2) |
8 | % | 10 | % | 2.29 | % | 2.39 | % | 2.24 | % | ||||||||||
| New York (2) |
5 | % | 11 | % | 2.93 | % | 3.05 | % | 2.82 | % | ||||||||||
| Illinois (2) |
4 | % | 6 | % | 2.57 | % | 2.61 | % | 2.51 | % | ||||||||||
| Arizona |
4 | % | 3 | % | 1.88 | % | 1.93 | % | 1.68 | % | ||||||||||
| Michigan |
4 | % | 3 | % | 1.78 | % | 1.94 | % | 1.72 | % | ||||||||||
| Georgia |
3 | % | 4 | % | 2.32 | % | 2.23 | % | 2.19 | % | ||||||||||
| North Carolina |
3 | % | 2 | % | 1.46 | % | 1.56 | % | 1.48 | % | ||||||||||
| Washington |
3 | % | 3 | % | 1.64 | % | 1.77 | % | 1.64 | % | ||||||||||
| (1) | Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. |
| (2) | Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be completed. |
| Percent of primary risk in-force as of March 31, 2024 |
Percent of direct primary case reserves as of March 31, 2024 (1) |
Delinquency rate as of | ||||||||||||||||||
| March 31, 2024 |
December 31, 2023 |
March 31, 2023 |
||||||||||||||||||
| By MSA or MD: |
||||||||||||||||||||
| Phoenix, AZ MSA |
3% | 3% | 1.93 | % | 2.01 | % | 1.72 | % | ||||||||||||
| Chicago-Naperville, IL MD |
3% | 4% | 2.91 | % | 2.88 | % | 2.77 | % | ||||||||||||
| Atlanta, GA MSA |
3% | 3% | 2.49 | % | 2.40 | % | 2.35 | % | ||||||||||||
| New York, NY MD |
2% | 7% | 3.37 | % | 3.60 | % | 3.51 | % | ||||||||||||
| Houston, TX MSA |
2% | 3% | 2.48 | % | 2.67 | % | 2.40 | % | ||||||||||||
| Washington-Arlington, DC MD |
2% | 2% | 1.93 | % | 2.01 | % | 1.79 | % | ||||||||||||
| Dallas, TX MD |
2% | 1% | 1.79 | % | 1.92 | % | 1.65 | % | ||||||||||||
| Los Angeles-Long Beach, CA MD |
2% | 3% | 2.32 | % | 2.39 | % | 2.24 | % | ||||||||||||
| Riverside-San Bernardino, CA MSA |
2% | 3% | 2.78 | % | 2.83 | % | 2.54 | % | ||||||||||||
| Denver-Aurora-Lakewood, CO MSA |
2% | 1% | 1.27 | % | 1.12 | % | 0.93 | % | ||||||||||||
| (1) | Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. |
91
Table of Contents
The following table sets forth the dispersion of Enact’s direct primary case reserves, primary insurance in-force and risk in-force by year of policy origination, and delinquency rate as of March 31, 2024:
| (Amounts in millions) |
Percent of direct primary case reserves (1) |
Primary insurance in-force |
Percent of total |
Primary risk in-force |
Percent of total |
Delinquency rate |
||||||||||||||||||
| Policy Year |
|
|||||||||||||||||||||||
| 2008 and prior |
15 | % | $ | 5,420 | 2 | % | $ | 1,397 | 2 | % | 8.12 | % | ||||||||||||
| 2009 to 2016 |
7 | 7,368 | 3 | 1,943 | 3 | 3.74 | % | |||||||||||||||||
| 2017 |
4 | 5,015 | 2 | 1,324 | 2 | 3.41 | % | |||||||||||||||||
| 2018 |
6 | 5,524 | 2 | 1,419 | 2 | 4.13 | % | |||||||||||||||||
| 2019 |
8 | 13,126 | 5 | 3,403 | 5 | 2.70 | % | |||||||||||||||||
| 2020 |
14 | 42,183 | 16 | 11,181 | 16 | 1.67 | % | |||||||||||||||||
| 2021 |
22 | 66,971 | 25 | 17,174 | 25 | 1.63 | % | |||||||||||||||||
| 2022 |
19 | 58,051 | 22 | 14,629 | 22 | 1.61 | % | |||||||||||||||||
| 2023 |
5 | 49,556 | 19 | 12,810 | 19 | 0.67 | % | |||||||||||||||||
| 2024 |
— | 10,431 | 4 | 2,670 | 4 | 0.02 | % | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Total portfolio |
100 | % | $ | 263,645 | 100 | % | $ | 67,950 | 100 | % | 2.01 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| (1) | Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. |
Loss reserves in policy years 2008 and prior are outsized compared to their representation of risk in-force. The size of these policy years at origination combined with the significant decline in home prices led to significant losses in policy years prior to 2009. Although uncertainty remains with respect to the ultimate losses Enact will experience on these policy years, they have become a smaller percentage of its total mortgage insurance portfolio. The concentration of loss reserves has shifted to newer book years in line with changes in risk in-force. As of March 31, 2024, Enact’s 2017 and newer policy years represented approximately 95% of its primary risk in-force and 78% of its total direct primary case reserves.
Long-Term Care Insurance segment
Trends and conditions
The long-term profitability of our long-term care insurance business depends upon how our actual experience compares with our valuation assumptions, including but not limited to in-force rate actions, morbidity, mortality and persistency. Estimates for in-force rate actions reflect certain simplifying assumptions that may vary materially from actual results, including but not limited to consistent policyholder behavior over time in addition to a uniform rate of coinsurance and premium taxes. Actual policyholder behavior may differ significantly from these assumptions. Results of our long-term care insurance business are also influenced by our ability to improve investment yields and manage expenses and reinsurance, among other factors. Changes in laws or government programs, including long-term care insurance rate action legislation, regulation and/or practices, could also impact our long-term care insurance business either positively or negatively.
Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments as our actual claims experience will emerge over many years, or decades. For example, average claim reserves for new claims have trended higher over time as the mix of claims continues to evolve, with an increasing number of policies with higher daily benefit amounts and higher inflation factors going on claim. Although new claim counts on certain of our oldest long-term care insurance blocks of business have reached their peak claim years and will decrease as the blocks run off, we are gaining more experience on the majority of our larger blocks of business and fully expect continued overall growth in new claims as policyholders reach their peak claim years.
92
Table of Contents
Additionally, in our long-term care insurance business, we have observed an increase in the cost of care in part due to elevated inflation. Increases in cost of care have resulted in higher claim payments in our long-term care insurance business, which could have a material adverse impact on our liquidity, results of operations and financial condition if it persists. We will continue to monitor our experience and make changes to our assumptions and methodologies, as appropriate, for our long-term care insurance products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition.
The impacts of assumption updates and actual versus expected experience will continue to drive volatility in our long-term care insurance results, particularly for our unprofitable capped cohorts. It is important to note that quarterly variations resulting from assumption updates and actual versus expected experience are typically expected to be relatively small compared to the overall size of our liability for future policy benefits of $42.2 billion, at the locked-in discount rate, for our long-term care insurance business as of March 31, 2024.
The financial condition of our long-term care insurance business is also impacted by interest rates. We remeasure our liability for future policy benefits and the related reinsurance recoverables at the single-A bond rate each quarter. As a result, our reported insurance liabilities are sensitive to movements in interest rates, which will likely result in continued volatility to our reserve balances and equity.
In-force rate actions and legal settlements
Given the ongoing challenges in our long-term care insurance business, we continue to pursue initiatives to improve the risk and profitability profile of our business, including premium rate increases and associated benefit reductions on our in-force policies. Executing on our multi-year long-term care insurance in-force rate action plan with premium rate increases and associated benefit reductions on our legacy long-term care insurance policies is critical to the business. For an update on in-force rate actions, refer to the selected operating performance measures below.
In addition, we have reached three legal settlements regarding alleged disclosure deficiencies in premium increases for long-term care insurance policies. These legal settlements cover approximately 70% of our long-term care insurance block and have helped accelerate benefit reductions. We began implementing the third and final legal settlement during the second quarter of 2023 and expect that settlement to be materially complete by the end of 2024.
While the legal settlements are similar, the ultimate impact depends on the policyholder election rates and the types of reduced benefits elected. Given our experience with prior settlements, we expect the third legal settlement to result in an overall net favorable economic impact to our long-term care insurance business as it reduces tail risk on these long-duration liabilities.
While we expect renewal premiums to decline over time as the block runs off, benefit reductions elected by policyholders in connection with our in-force rate actions and legal settlements have accelerated that decline. However, we expect this decline to be partially offset by future approved rate actions.
93
Table of Contents
Segment results of operations
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
The following table sets forth the results of operations relating to our Long-Term Care Insurance segment for the periods indicated:
| Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
| (Amounts in millions) |
2024 | 2023 | 2024 vs. 2023 | |||||||||||||
| Revenues: |
||||||||||||||||
| Premiums |
$ | 578 | $ | 616 | $ | (38 | ) | (6 | )% | |||||||
| Net investment income |
464 | 473 | (9 | ) | (2 | )% | ||||||||||
| Net investment gains (losses) |
63 | 9 | 54 | NM | (1) | |||||||||||
|
|
|
|
|
|
|
|||||||||||
| Total revenues |
1,105 | 1,098 | 7 | 1 | % | |||||||||||
|
|
|
|
|
|
|
|||||||||||
| Benefits and expenses: |
||||||||||||||||
| Benefits and other changes in policy reserves |
936 | 944 | (8 | ) | (1 | )% | ||||||||||
| Liability remeasurement (gains) losses |
(16 | ) | (32 | ) | 16 | 50 | % | |||||||||
| Acquisition and operating expenses, net of deferrals |
102 | 119 | (17 | ) | (14 | )% | ||||||||||
| Amortization of deferred acquisition costs and intangibles |
17 | 18 | (1 | ) | (6 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Total benefits and expenses |
1,039 | 1,049 | (10 | ) | (1 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Income from continuing operations before income taxes |
66 | 49 | 17 | 35 | % | |||||||||||
| Provision for income taxes |
14 | 18 | (4 | ) | (22 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Income from continuing operations |
52 | 31 | 21 | 68 | % | |||||||||||
| Adjustments to income from continuing operations: |
||||||||||||||||
| Net investment (gains) losses |
(63 | ) | (9 | ) | (54 | ) | NM | (1) | ||||||||
| Expenses related to restructuring |
1 | (1 | ) | 2 | 200 | % | ||||||||||
| Taxes on adjustments |
13 | 2 | 11 | NM | (1) | |||||||||||
|
|
|
|
|
|
|
|||||||||||
| Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 3 | $ | 23 | $ | (20 | ) | (87 | )% | |||||||
|
|
|
|
|
|
|
|||||||||||
| (1) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders
Adjusted operating income decreased primarily driven by less favorable mortality and lower renewal premiums in the current year. The prior year included an unfavorable cash flow assumption update related to implementation timing of our in-force rate action plan, as well as a legal settlement accrual that did not recur.
Revenues
Premiums, including from in-force rate actions approved and implemented, decreased primarily driven by lower renewal premiums from policy terminations and policies entering paid-up status in the current year.
Net investment income decreased largely from lower income from limited partnerships in the current year.
For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”
94
Table of Contents
Benefits and expenses
Benefits and other changes in policy reserves decreased primarily from policy terminations, partially offset by aging of the in-force block, including higher interest accretion in the current year.
The liability remeasurement gain decreased mainly due to less favorable mortality in the current year, partially offset by an unfavorable cash flow assumption update related to implementation timing of our in-force rate action plan in the prior year.
Acquisition and operating expenses, net of deferrals, decreased principally from a $13 million accrual for legal settlement costs in the prior year that did not recur.
Provision for income taxes. The effective tax rate was 21.0% and 37.1% for the three months ended March 31, 2024 and 2023, respectively. The decrease in the effective tax rate was primarily attributable to differing levels of ordinary income in relation to tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income.
Long-Term Care Insurance selected operating performance measures
Liability remeasurement (gains) losses
We include expectations for benefit reductions related to in-force rate actions and legal settlements as well as settlement payments in our assumptions for the liability for future policy benefits, which have impacted and will continue to impact our reported U.S. GAAP financial results. We update the net premium ratio quarterly for actual versus expected experience; therefore, forecasted cash flow assumptions will be replaced with actual cash flows each quarter with any difference recorded in net income (loss). As a result, variances between actual experience and our expectations for benefit reductions will be reflected in liability remeasurement (gains) losses in our operating results on a quarterly basis.
We experienced quarterly fluctuations in actual to expected experience in 2023 related to the second legal settlement which primarily impacted older, unprofitable capped cohorts, after including this settlement in our 2022 assumptions. However, the third legal settlement, for which we updated cash flow assumptions in the fourth quarter of 2023, impacts profitable uncapped cohorts and has a more muted earnings impact. Overall, we expect the legal settlements to result in a net favorable economic impact to our long-term care insurance business as they reduce tail risk on these long-duration liabilities.
The following table sets forth the pre-tax components of the liability remeasurement (gains) losses for the periods indicated:
| Three months ended March 31, |
(Increase) decrease and percentage change |
|||||||||||||||
| (Amounts in millions) |
2024 | 2023 | 2024 vs. 2023 | |||||||||||||
| Cash flow assumption updates |
$ | (2 | ) | $ | 21 | $ | (23 | ) | (110 | )% | ||||||
| Actual to expected experience |
(14 | ) | (53 | ) | 39 | 74 | % | |||||||||
|
|
|
|
|
|
|
|||||||||||
| Total liability remeasurement (gains) losses |
$ | (16 | ) | $ | (32 | ) | $ | 16 | 50 | % | ||||||
|
|
|
|
|
|
|
|||||||||||
For additional discussion of the change in liability remeasurement (gains) losses, see the comparison for this line item above in “—Segment results of operations.”
In-force rate actions
As part of our strategy for our long-term care insurance business, we have been implementing, and expect to continue to pursue, significant premium rate increases and associated benefit reductions in order to ensure the
95
Table of Contents
continued self-sustainability of the legacy life insurance subsidiaries over time and reduce the strain on earnings and capital.
The following table sets forth filing approvals as part of our multi-year in-force rate action plan for the periods indicated:
| Three months ended March 31, | ||||||||
| (Dollar amounts in millions) |
2024 | 2023 | ||||||
| State filings approved |
23 | 23 | ||||||
| Impacted in-force premiums |
$ | 166 | $ | 78 | ||||
| Weighted-average percentage rate increase approved |
25 | % | 64 | % | ||||
| Gross incremental premiums approved |
$ | 41 | $ | 50 | ||||
During the first quarter of 2024, we also submitted five new filings on approximately $41 million in annualized in-force premiums.
The approval process for in-force rate actions and the amount and timing of the premium rate increases and associated benefit reductions approved vary by state and product. In certain states, the decision to approve or disapprove a rate increase can take a significant amount of time, and the approved amount may be phased in over time. After approval, insureds are provided with written notice of the increase and increases are generally applied on the insured’s next policy anniversary date. As a result, the benefits of any rate increase are not fully realized until the implementation cycle is complete and are, therefore, expected to be realized over time.
We continue to work closely with the National Association of Insurance Commissioners and state regulators to demonstrate the broad-based need for actuarially justified rate increases in order to pay future claims. Because obtaining actuarially justified rate increases and associated benefit reductions is important to our ability to pay future claims, we will consider litigation against states that decline to approve those actuarially justified rate increases. As of March 31, 2024, we were in litigation with two states that have refused to approve actuarially justified rate increases for certain products.
Life and Annuities segment
Trends and conditions
Many factors can affect the results of our life insurance and annuity products, as further discussed below. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. We will continue to monitor our experience and assumptions closely and make changes to our assumptions and methodologies, as appropriate, for our life insurance and annuity products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition. Results of our life insurance and annuity products depend significantly upon the extent to which our actual future experience is consistent with assumptions and methodologies we have used in calculating our reserves. Results of our life insurance and annuity products are also impacted by interest rates. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates, including changes in monetary policy to combat inflation, could materially adversely affect our business and profitability” in our 2023 Annual Report on Form 10-K.
We no longer solicit sales of traditional life insurance and annuity products; however, we continue to service our existing retained and reinsured blocks of business.
Life insurance
Results of our life insurance products are impacted primarily by mortality, persistency, investment yields, expenses, reinsurance and statutory reserve requirements, among other factors.
96
Table of Contents
Mortality levels may deviate each period from historical trends. We have typically observed seasonally higher mortality during the first quarter as compared to the remaining quarters of the year. However, overall mortality experience was less unfavorable during the first quarter of 2024 compared to the first quarter of 2023 and the fourth quarter of 2023, largely in our universal life insurance products. The updates to our mortality assumptions in the fourth quarter of 2023, which increased expected mortality, also contributed to the less unfavorable mortality experience observed in the first quarter of 2024 compared to expectations. We have experienced unfavorable mortality compared to our then-current and priced-for assumptions in recent years for our universal life insurance block. Reinsurance costs typically increase due to natural aging of the yearly renewable term (“YRT”) reinsured blocks. We have also received some YRT reinsurance premium increases from some of our YRT reinsurance partners that reflect unfavorable mortality.
Fixed annuities
Results of our fixed annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, persistency and expense and commission levels.
We monitor and change crediting rates on fixed deferred annuities on a regular basis to maintain spreads and targeted returns, if applicable. However, we have seen and could continue to see declines in our fixed annuity spreads and margins as interest rates change, depending on the severity of the change.
For fixed indexed annuities, equity market and interest rate performance and volatility could also result in additional gains or losses, although associated hedging activities are expected to partially mitigate these impacts.
Variable annuities
Results of our variable annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, surrenders and scheduled maturities. In addition, the results of our variable annuity products can significantly impact our regulatory capital requirements, distributable earnings and liquidity. We use hedging strategies as well as liquidity planning and asset-liability management to help mitigate the impacts. In addition, we have used reinsurance to help mitigate volatility in our variable annuity results.
Equity market volatility and interest rate movements have caused fluctuations in the results of our variable annuity products and regulatory capital requirements. In the future, equity market and interest rate performance and volatility could result in additional gains or losses in these products, although associated hedging activities are expected to partially mitigate these impacts.
97
Table of Contents
Segment results of operations
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
The following table sets forth the results of operations relating to our Life and Annuities segment for the periods indicated:
| Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
| (Amounts in millions) |
2024 | 2023 | 2024 vs. 2023 | |||||||||||||
| Revenues: |
||||||||||||||||
| Premiums |
$ | 53 | $ | 62 | $ | (9 | ) | (15 | )% | |||||||
| Net investment income |
254 | 264 | (10 | ) | (4 | )% | ||||||||||
| Net investment gains (losses) |
(4 | ) | (10 | ) | 6 | 60 | % | |||||||||
| Policy fees and other income |
158 | 163 | (5 | ) | (3 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Total revenues |
461 | 479 | (18 | ) | (4 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Benefits and expenses: |
||||||||||||||||
| Benefits and other changes in policy reserves |
250 | 246 | 4 | 2 | % | |||||||||||
| Liability remeasurement (gains) losses |
8 | 17 | (9 | ) | (53 | )% | ||||||||||
| Changes in fair value of market risk benefits and associated hedges |
(23 | ) | 17 | (40 | ) | NM | (1) | |||||||||
| Interest credited |
125 | 126 | (1 | ) | (1 | )% | ||||||||||
| Acquisition and operating expenses, net of deferrals |
54 | 53 | 1 | 2 | % | |||||||||||
| Amortization of deferred acquisition costs and intangibles |
45 | 51 | (6 | ) | (12 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Total benefits and expenses |
459 | 510 | (51 | ) | (10 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Income (loss) from continuing operations before income taxes |
2 | (31 | ) | 33 | 106 | % | ||||||||||
| Benefit for income taxes |
— | (7 | ) | 7 | 100 | % | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Income (loss) from continuing operations |
2 | (24 | ) | 26 | 108 | % | ||||||||||
| Adjustments to income (loss) from continuing operations: |
||||||||||||||||
| Net investment (gains) losses |
4 | 10 | (6 | ) | (60 | )% | ||||||||||
| Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges(2) |
(26 | ) | 14 | (40 | ) | NM | (1) | |||||||||
| Taxes on adjustments |
5 | (4 | ) | 9 | NM | (1) | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders |
$ | (15 | ) | $ | (4 | ) | $ | (11 | ) | NM | (1) | |||||
|
|
|
|
|
|
|
|||||||||||
| (1) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
| (2) | For the three months ended March 31, 2024 and 2023, changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(3) million in each period. |
98
Table of Contents
The following table sets forth adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for the products included in our Life and Annuities segment for the periods indicated:
| Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
| (Amounts in millions) |
2024 | 2023 | 2024 vs. 2023 | |||||||||||||
| Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
| Life insurance |
$ | (33 | ) | $ | (27 | ) | $ | (6 | ) | (22 | )% | |||||
| Fixed annuities |
11 | 14 | (3 | ) | (21 | )% | ||||||||||
| Variable annuities |
7 | 9 | (2 | ) | (22 | )% | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Total adjusted operating loss available to Genworth Financial, Inc.’s common stockholders |
$ | (15 | ) | $ | (4 | ) | $ | (11 | ) | NM | (1) | |||||
|
|
|
|
|
|
|
|||||||||||
| (1) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders
| • | The adjusted operating loss in our life insurance products increased primarily due to lower premiums and product charges reflecting the runoff of our in-force blocks, partially offset by less unfavorable mortality experience in the current year. |
| • | Adjusted operating income in our fixed annuity products decreased mainly from lower net spreads primarily related to block runoff in the current year. |
Revenues
Premiums. The decrease was driven by our life insurance products largely due to the continued runoff of our in-force blocks in the current year.
Net investment income. The decrease was primarily attributable to lower average invested assets driven mostly by block runoff in our fixed annuity products in the current year.
Net investment gains (losses). For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”
Policy fees and other income. The decrease was driven mostly by lower product charges in our life insurance products due to the runoff of our in-force blocks in the current year.
Benefits and expenses
Benefits and other changes in policy reserves
| • | Our life insurance products increased $9 million primarily from a lower favorable change in reserves in our term life insurance products related to block runoff and from aging of the in-force block in our universal life insurance products, partially offset by less unfavorable mortality in the current year. |
| • | Our fixed annuity products decreased $3 million largely from block runoff in the current year. |
Liability remeasurement (gains) losses. The decrease in the loss was driven mostly by less unfavorable mortality in our life insurance products in the current year.
99
Table of Contents
Changes in fair value of market risk benefits and associated hedges
| • | Our variable annuity products had a favorable variance of $25 million primarily attributable to a favorable change in the interest rate yield curve, partially offset by higher derivative losses in the current year. |
| • | Our fixed annuity products had a favorable variance of $15 million primarily driven by higher interest rates in the current year. |
Amortization of deferred acquisition costs and intangibles. The decrease was largely due to block runoff in our term life insurance products in the current year.
Benefit for income taxes. The effective tax rate was 21.0% and 22.4% for the three months ended March 31, 2024 and 2023, respectively. The decrease in the effective tax rate was primarily attributable to differing levels of ordinary income in relation to tax benefits from tax favored items.
Life and Annuities selected operating performance measures
Life insurance
The following table sets forth selected operating performance measures regarding our life insurance products as of the dates indicated:
| March 31, | Increase (decrease) and percentage change |
|||||||||||||||
| (Amounts in millions) |
2024 | 2023 | 2024 vs. 2023 | |||||||||||||
| Term and whole life insurance |
||||||||||||||||
| Life insurance in-force, net of reinsurance |
$ | 43,512 | $ | 46,964 | $ | (3,452 | ) | (7 | )% | |||||||
| Life insurance in-force, before reinsurance |
$ | 263,727 | $ | 292,091 | $ | (28,364 | ) | (10 | )% | |||||||
| Term universal life insurance |
||||||||||||||||
| Life insurance in-force, net of reinsurance |
$ | 90,054 | $ | 91,817 | $ | (1,763 | ) | (2 | )% | |||||||
| Life insurance in-force, before reinsurance |
$ | 90,648 | $ | 92,431 | $ | (1,783 | ) | (2 | )% | |||||||
| Universal life insurance |
||||||||||||||||
| Life insurance in-force, net of reinsurance |
$ | 28,306 | $ | 29,475 | $ | (1,169 | ) | (4 | )% | |||||||
| Life insurance in-force, before reinsurance |
$ | 31,831 | $ | 33,246 | $ | (1,415 | ) | (4 | )% | |||||||
The decrease in insurance in-force in our life insurance products reflects the continued runoff of our in-force blocks.
100
Table of Contents
Corporate and Other
Results of operations
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
The following table sets forth the results of operations relating to Corporate and Other for the periods indicated:
| Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
| (Amounts in millions) |
2024 | 2023 | 2024 vs. 2023 | |||||||||||||
| Revenues: |
||||||||||||||||
| Premiums |
$ | 3 | $ | 2 | $ | 1 | 50 | % | ||||||||
| Net investment income |
7 | 4 | 3 | 75 | % | |||||||||||
| Net investment gains (losses) |
(4 | ) | (10 | ) | 6 | 60 | % | |||||||||
|
|
|
|
|
|
|
|||||||||||
| Total revenues |
6 | (4 | ) | 10 | NM | (1) | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Benefits and expenses: |
||||||||||||||||
| Benefits and other changes in policy reserves |
(3 | ) | (3 | ) | — | — | % | |||||||||
| Acquisition and operating expenses, net of deferrals |
29 | 16 | 13 | 81 | % | |||||||||||
| Amortization of deferred acquisition costs and intangibles |
1 | — | 1 | NM | (1) | |||||||||||
| Interest expense |
17 | 16 | 1 | 6 | % | |||||||||||
|
|
|
|
|
|
|
|||||||||||
| Total benefits and expenses |
44 | 29 | 15 | 52 | % | |||||||||||
|
|
|
|
|
|
|
|||||||||||
| Loss from continuing operations before income taxes |
(38 | ) | (33 | ) | (5 | ) | (15 | )% | ||||||||
| Provision (benefit) for income taxes |
7 | (5 | ) | 12 | NM | (1) | ||||||||||
|
|
|
|
|
|
|
|||||||||||
| Loss from continuing operations |
(45 | ) | (28 | ) | (17 | ) | (61 | )% | ||||||||
| Adjustments to loss from continuing operations: |
||||||||||||||||
| Net investment (gains) losses |
4 | 10 | (6 | ) | (60 | )% | ||||||||||
| (Gains) losses on early extinguishment of debt |
(1 | ) | (1 | ) | — | — | % | |||||||||
| Expenses related to restructuring |
6 | 4 | 2 | 50 | % | |||||||||||
| Taxes on adjustments |
(2 | ) | (3 | ) | 1 | 33 | % | |||||||||
|
|
|
|
|
|
|
|||||||||||
| Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders |
$ | (38 | ) | $ | (18 | ) | $ | (20 | ) | (111 | )% | |||||
|
|
|
|
|
|
|
|||||||||||
| (1) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders
The adjusted operating loss increased primarily from timing of certain tax related items in the current year and higher expenses related to CareScout growth initiatives.
Revenues
For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”
Benefits and expenses
Acquisition and operating expenses, net of deferrals, increased primarily from higher expenses related to CareScout growth initiatives, as well as higher employee-related expenses in the current year.
101
Table of Contents
The provision for income taxes for the three months ended March 31, 2024 was primarily related to timing of tax adjustments, partially offset by the tax benefit related to the pre-tax loss. The benefit for income taxes for the three months ended March 31, 2023 was largely from the pre-tax loss, partially offset by non-deductible expenses.
Investments and Derivative Instruments
Trends and conditions
Investments
During the three months ended March 31, 2024, our investment portfolio was impacted, and we believe will continue to be impacted, by the following macroeconomic trends:
| • | The U.S. Federal Reserve kept interest rates unchanged during the first quarter of 2024 as it continues to monitor inflation. |
| • | During the first quarter of 2024, both short-term and long-term U.S. Treasury yields increased compared to December 31, 2023. The two-year U.S. Treasury yield remained above the ten-year U.S. Treasury yield as of March 31, 2024, with the differential between the two-year yield and the ten-year yield consistent with the differential as of December 31, 2023. |
| • | Credit spreads tightened and credit market performance remained strong in the first quarter of 2024 as macroeconomic data continued to support market optimism for a soft economic landing. |
| • | As of March 31, 2024, our investment portfolio exposure to Israel was immaterial and there has been no impact on our results of operations from the Israel-Hamas conflict. At this time, we do not believe there is a material risk to the valuation of our investment portfolio due to credit losses or direct write-offs that may arise as a result of the conflict. |
| • | As of March 31, 2024, our fixed maturity securities portfolio, which was 96% investment grade, comprised 75% of our total invested assets and cash. |
Derivatives
| • | As of March 31, 2024, $1.2 billion notional of our derivatives portfolio was cleared through the Chicago Mercantile Exchange (“CME”). |
| • | The customer swap agreements that govern our cleared derivatives contain provisions that enable our clearing agents to request initial margin in excess of CME requirements. As of March 31, 2024, we posted initial margin of $70 million to our clearing agents, which represented $35 million more than was otherwise required by the clearinghouse. Because our clearing agents serve as guarantors of our obligations to the CME, the customer agreements contain broad termination provisions that are not specifically dependent on ratings. |
| • | As of March 31, 2024, $12.4 billion notional of our derivatives portfolio was in bilateral over-the-counter derivative transactions pursuant to which we have posted aggregate independent amounts of $511 million and are holding collateral from counterparties in the amount of $16 million. |
102
Table of Contents
Investment results
The following table sets forth information about investment income, excluding net investment gains (losses), for each component of our investment portfolio for the periods indicated:
| Three months ended March 31, | Increase (decrease) | |||||||||||||||||||||||
| 2024 | 2023 | 2024 vs. 2023 | ||||||||||||||||||||||
| (Amounts in millions) |
Yield | Amount | Yield | Amount | Yield | Amount | ||||||||||||||||||
| Fixed maturity securities—taxable |
4.5 | % | $ | 554 | 4.4 | % | $ | 561 | 0.1 | % | $ | (7 | ) | |||||||||||
| Fixed maturity securities—non-taxable |
10.8 | % | 1 | 4.6 | % | 1 | 6.2 | % | — | |||||||||||||||
| Equity securities |
1.9 | % | 2 | 2.3 | % | 2 | (0.4 | )% | — | |||||||||||||||
| Commercial mortgage loans |
4.4 | % | 75 | 4.4 | % | 76 | — | % | (1 | ) | ||||||||||||||
| Policy loans |
10.5 | % | 58 | 10.3 | % | 55 | 0.2 | % | 3 | |||||||||||||||
| Limited partnerships (1) |
2.8 | % | 20 | 4.7 | % | 28 | (1.9 | )% | (8 | ) | ||||||||||||||
| Other invested assets (2) |
47.7 | % | 68 | 51.6 | % | 68 | (3.9 | )% | — | |||||||||||||||
| Cash, cash equivalents, restricted cash and short-term investments |
5.1 | % | 27 | 4.0 | % | 18 | 1.1 | % | 9 | |||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||
| Gross investment income before expenses and fees |
5.0 | % | 805 | 5.0 | % | 809 | — | % | (4 | ) | ||||||||||||||
| Expenses and fees |
(0.1 | )% | (23 | ) | (0.1 | )% | (22 | ) | — | % | (1 | ) | ||||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||
| Net investment income |
4.9 | % | $ | 782 | 4.9 | % | $ | 787 | — | % | $ | (5 | ) | |||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||
| Average invested assets and cash |
$ | 64,265 | $ | 64,768 | $ | (503 | ) | |||||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||
| (1) | Limited partnership investments are primarily equity-based and do not have fixed returns by period. |
| (2) | Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation. |
Yields are based on net investment income as reported under U.S. GAAP and are consistent with how we measure our investment performance for management purposes. Yields are annualized, for interim periods, and are calculated as net investment income as a percentage of average quarterly asset carrying values except for fixed maturity securities, derivatives and derivative counterparty collateral, which exclude unrealized fair value adjustments.
Annualized weighted-average investment yields were unchanged; however, net investment income decreased slightly primarily due to lower average invested assets.
103
Table of Contents
The following table sets forth net investment gains (losses) for the periods indicated:
| Three months ended March 31, |
||||||||
| (Amounts in millions) |
2024 | 2023 | ||||||
| Realized investment gains (losses): |
||||||||
| Available-for-sale fixed maturity securities: |
||||||||
| Realized gains |
$ | 7 | $ | 3 | ||||
| Realized losses |
(29 | ) | (19 | ) | ||||
|
|
|
|
|
|||||
| Net realized gains (losses) on available-for-sale fixed maturity securities |
(22 | ) | (16 | ) | ||||
| Net realized gains (losses) on equity securities sold |
— | — | ||||||
|
|
|
|
|
|||||
| Total net realized investment gains (losses) |
(22 | ) | (16 | ) | ||||
|
|
|
|
|
|||||
| Net change in allowance for credit losses on available-for-sale fixed maturity securities |
— | (15 | ) | |||||
| Net unrealized gains (losses) on equity securities still held |
32 | 11 | ||||||
| Net unrealized gains (losses) on limited partnerships |
43 | — | ||||||
| Commercial mortgage loans |
(2 | ) | (2 | ) | ||||
| Derivative instruments |
1 | 12 | ||||||
| Other |
(3 | ) | (1 | ) | ||||
|
|
|
|
|
|||||
| Net investment gains (losses) |
$ | 49 | $ | (11 | ) | |||
|
|
|
|
|
|||||
| • | The three months ended March 31, 2024 included $43 million of net unrealized gains on limited partnerships driven by favorable private equity market performance. We also recorded $21 million of higher net unrealized gains on equity securities during the three months ended March 31, 2024 compared to the three months ended March 31, 2023 driven by more favorable equity market performance. During the three months ended March 31, 2023, we recorded an allowance for credit losses on available for sale fixed-maturity securities of $15 million. |
| • | We had $11 million of lower net gains related to derivatives during the three months ended March 31, 2024 compared to the three months ended March 31, 2023 primarily attributable to losses from forward bond purchase commitments in the current year, as well as higher losses associated with our fixed indexed annuity embedded derivatives. |
Investment portfolio
The following table sets forth our cash, cash equivalents and invested assets as of the dates indicated:
| March 31, 2024 | December 31, 2023 | |||||||||||||||
| (Amounts in millions) |
Carrying value | % of total | Carrying value | % of total | ||||||||||||
| Available-for-sale fixed maturity securities: |
||||||||||||||||
| Public |
$ | 31,412 | 51 | % | $ | 32,189 | 51 | % | ||||||||
| Private |
14,653 | 24 | 14,592 | 24 | ||||||||||||
| Equity securities |
427 | 1 | 396 | 1 | ||||||||||||
| Commercial mortgage loans, net |
6,719 | 11 | 6,802 | 10 | ||||||||||||
| Policy loans |
2,219 | 4 | 2,220 | 4 | ||||||||||||
| Limited partnerships |
2,949 | 5 | 2,821 | 5 | ||||||||||||
| Other invested assets |
683 | 1 | 731 | 1 | ||||||||||||
| Cash, cash equivalents and restricted cash |
1,952 | 3 | 2,215 | 4 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total cash, cash equivalents and invested assets |
$ | 61,014 | 100 | % | $ | 61,966 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
104
Table of Contents
For a discussion of the change in cash, cash equivalents and invested assets, see the comparison for these line items under “—Consolidated Balance Sheets.” See note 4 in our unaudited condensed consolidated financial statements under “Item 1—Financial Statements” for additional information related to our investment portfolio.
We hold fixed maturity and equity securities, limited partnerships, derivatives, embedded derivatives and certain other financial instruments, which are carried at fair value. Fair value is the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. As of March 31, 2024, approximately 7% of our investment holdings recorded at fair value was based on significant inputs that were not market observable and were classified as Level 3 measurements. See note 6 in our unaudited condensed consolidated financial statements under “Item 1—Financial Statements” for additional information related to fair value.
Other invested assets
The following table sets forth the carrying values of our other invested assets as of the dates indicated:
| March 31, 2024 | December 31, 2023 | |||||||||||||||
| (Amounts in millions) |
Carrying value | % of total | Carrying value | % of total | ||||||||||||
| Bank loan investments |
$ | 520 | 76 | % | $ | 529 | 72 | % | ||||||||
| Derivatives |
107 | 16 | 131 | 18 | ||||||||||||
| Short-term investments |
10 | 1 | 27 | 4 | ||||||||||||
| Other investments |
46 | 7 | 44 | 6 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total other invested assets |
$ | 683 | 100 | % | $ | 731 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
Derivatives decreased largely from an increase in interest rates in the current year. Short-term investments decreased from maturities and sales in the current year.
Derivatives
The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for fixed indexed annuity and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated:
| (Notional in millions) |
Measurement | December 31, 2023 |
Additions | Maturities/ terminations |
March 31, 2024 |
|||||||||||||||
| Derivatives designated as hedges |
|
|||||||||||||||||||
| Cash flow hedges: |
||||||||||||||||||||
| Interest rate swaps |
Notional | $ | 8,975 | $ | 231 | $ | (101 | ) | $ | 9,105 | ||||||||||
| Foreign currency swaps |
Notional | 131 | 13 | — | 144 | |||||||||||||||
| Forward bond purchase commitments |
Notional | 1,075 | 934 | — | 2,009 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total cash flow hedges |
10,181 | 1,178 | (101 | ) | 11,258 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total derivatives designated as hedges |
10,181 | 1,178 | (101 | ) | 11,258 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Derivatives not designated as hedges |
||||||||||||||||||||
| Equity index options |
Notional | 702 | 178 | (209 | ) | 671 | ||||||||||||||
| Financial futures |
Notional | 1,251 | 1,191 | (1,268 | ) | 1,174 | ||||||||||||||
| Forward bond purchase commitments |
Notional | 500 | — | — | 500 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total derivatives not designated as hedges |
2,453 | 1,369 | (1,477 | ) | 2,345 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total derivatives |
$ | 12,634 | $ | 2,547 | $ | (1,578 | ) | $ | 13,603 | |||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
| (Number of policies) |
Measurement | December 31, 2023 |
Additions | Maturities/ terminations |
March 31, 2024 |
|||||||||||||||
| Derivatives not designated as hedges |
||||||||||||||||||||
| Fixed indexed annuity embedded derivatives |
Policies | 5,826 | — | (272 | ) | 5,554 | ||||||||||||||
| Indexed universal life embedded derivatives |
Policies | 749 | — | (12 | ) | 737 | ||||||||||||||
105
Table of Contents
The increase in the notional value of derivatives was primarily attributable to the addition of forward bond purchase commitments and interest rate swaps that support our long-term care and universal life insurance businesses, partially offset by a decrease in financial futures that support our variable annuity products.
The number of policies with embedded derivatives decreased as these products are no longer being offered and continue to runoff.
Consolidated Balance Sheets
Total assets. Total assets decreased $1,625 million from $90,817 million as of December 31, 2023 to $89,192 million as of March 31, 2024.
| • | Invested assets decreased $689 million primarily attributable to decreases of $716 million in fixed maturity securities and $83 million in commercial mortgage loans, partially offset by an increase of $128 million in limited partnerships. The decrease in fixed maturity securities was predominantly related to higher interest rates reducing the fair value of our fixed maturity investment portfolio and from net sales and maturities in the current year. Commercial mortgage loans decreased mostly due to payments outpacing originations, and limited partnerships increased largely from capital calls in the current year. |
| • | Cash and cash equivalents decreased $263 million largely due to net withdrawals from our investment contracts, settlements of derivatives that support our variable annuity products with guaranteed minimum benefits and repurchases of Genworth Financial’s common stock in the current year, partially offset by net sales and maturities of fixed maturity securities. |
| • | Reinsurance recoverable decreased $737 million primarily due to an increase in the single-A interest rate used to discount the reinsurance recoverable and from the runoff of certain ceded products. |
| • | Deferred tax asset decreased $113 million principally from a reduction in insurance reserves and the related reinsurance recoverables due to an increase in the single-A interest rate, partially offset by an increase in net unrealized losses on investments due to rising interest rates in the current year. |
| • | Separate account assets (and liabilities) increased $136 million primarily driven by favorable equity market performance, partially offset by surrenders, withdrawals and benefit payments in the current year. |
Total liabilities. Total liabilities decreased $2,169 million from $82,482 million as of December 31, 2023 to $80,313 million as of March 31, 2024.
| • | The liability for future policy benefits decreased $2,110 million primarily from an increase in the single-A interest rate used to discount the liability for future policy benefits and from the runoff of our life insurance and annuity products in the current year. |
| • | Policyholder account balances decreased $225 million largely driven by surrenders, withdrawals and benefit payments in our fixed annuity products in the current year. |
| • | Market risk benefit liabilities decreased $97 million mostly related to favorable equity market performance and interest rate changes in the current year. |
Total equity. Total equity increased $544 million from $8,335 million as of December 31, 2023 to $8,879 million as of March 31, 2024.
| • | We reported net income available to Genworth Financial, Inc.’s common stockholders of $139 million for the three months ended March 31, 2024. |
| • | Unrealized gains (losses) on investments and derivatives qualifying as hedges decreased total equity by $485 million and $161 million, respectively, primarily due to an increase in interest rates in the current year. |
106
Table of Contents
| • | Change in the discount rate used to measure future policy benefits increased total equity by $1,105 million largely attributable to an increase in the single-A interest rate used to discount the liability for future policy benefits and the related reinsurance recoverables in the current year. |
| • | Treasury stock increased $63 million due to the repurchase of Genworth Financial’s common stock, at cost, including excise taxes and other costs paid in connection with acquiring the shares, resulting in a decrease to total equity in the current year. |
Liquidity and Capital Resources
Liquidity and capital resources represent our overall financial strength and our ability to generate cash flows from our businesses, borrow funds at competitive rates and raise new capital to meet our operating and growth needs.
Overview of cash flows—Genworth and subsidiaries
The following table sets forth our unaudited condensed consolidated cash flows for the three months ended March 31:
| (Amounts in millions) |
2024 | 2023 | ||||||
| Net cash from (used by) operating activities |
$ | (107 | ) | $ | 17 | |||
| Net cash from investing activities |
143 | 364 | ||||||
| Net cash used by financing activities |
(299 | ) | (428 | ) | ||||
|
|
|
|
|
|||||
| Net decrease in cash and cash equivalents |
$ | (263 | ) | $ | (47 | ) | ||
|
|
|
|
|
|||||
Our principal sources of cash include sales of our products and services, income from our investment portfolio and proceeds from sales of investments. As an insurance business, we typically generate positive cash flows from operating activities, as premiums collected from our insurance products and income received from our investments typically exceed policy acquisition costs, benefits and claims paid, redemptions and operating expenses. Our cash flows from operating activities are affected by the timing of premiums, fees and investment income received and benefits, claims and expenses paid. Positive cash flows from operating activities are then invested to support the obligations of our insurance and investment products and required capital supporting these products. In analyzing our cash flows, we focus on the change in the amount of cash available and used in investing activities. Changes in cash from financing activities primarily relate to deposits to, and redemptions and benefit payments on, universal life insurance and investment contracts; the issuance of debt and equity securities; the repayment or repurchase of borrowings; the repurchase of common stock presented as treasury stock; and other capital transactions.
We had net cash outflows related to operating activities in the current year compared to net inflows in the prior year primarily from settlements of derivatives that support our variable annuity products with guaranteed minimum benefits and lower premiums collected in our long-term care insurance business.
Net cash inflows from investing activities were lower in the current year mainly due to lower net sales and maturities of fixed maturity securities, partially offset by lower capital calls on limited partnerships.
Net cash outflows used by financing activities were lower in the current year primarily due to lower net withdrawals from our investment contracts.
Genworth—holding company liquidity
In consideration of our liquidity, it is important to separate the needs of our holding companies from the needs of their respective subsidiaries. Genworth Financial and Genworth Holdings each act as a holding
107
Table of Contents
company for their respective subsidiaries and do not have any significant operations of their own. Genworth Financial’s and Genworth Holdings’ principal sources of cash are derived from dividends and other returns of capital from Enact Holdings. Additional sources of cash have included subsidiary payments to them under tax sharing and expense reimbursement arrangements and proceeds from borrowings or securities issuances. The primary uses of funds at Genworth Financial and Genworth Holdings include payments of principal, interest and other expenses on borrowings or other obligations, payment of holding company general operating expenses (including employee benefits and taxes), payments under guarantees (including guarantees of certain subsidiary obligations), payments to subsidiaries (and, in the case of Genworth Holdings, to Genworth Financial) under tax sharing agreements, contributions to subsidiaries, repurchases of debt securities, repurchases of Genworth Financial’s common stock and, in the case of Genworth Holdings, loans, dividends or other distributions to Genworth Financial.
Management’s focus is predominantly on Genworth Holdings’ liquidity given it is the issuer of our outstanding public debt. We manage our U.S. life insurance subsidiaries on a standalone basis and accordingly, do not expect to receive any dividends or other returns of capital from them. Therefore, our liquidity at the holding company level is highly dependent on the performance of Enact Holdings, its capacity to maintain sufficient cash to pay its debt maturities and other obligations when due and its ability to pay timely dividends and other forms of capital returns to Genworth Holdings as anticipated. Genworth Financial has the right to appoint a majority of directors to the board of directors of Enact Holdings; however, actions taken by Enact Holdings and its board of directors are subject to and may be limited by the interests of Enact Holdings, including but not limited to, its use of capital for growth opportunities and regulatory requirements. Future dividends will be subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial and will also be dependent on a variety of economic, market and business conditions, among other considerations. In addition, insurance laws and regulations regulate the payment of dividends and other distributions to Genworth Financial and Genworth Holdings by their insurance subsidiaries.
On May 1, 2024, Enact Holdings announced an increase of its next quarterly dividend from $0.16 to $0.185 per share to be paid in June 2024. In addition to its quarterly cash dividend program, on August 1, 2023, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings may repurchase up to $100 million of its outstanding common stock. On May 1, 2024, Enact Holdings announced a new share repurchase authorization of $250 million. Genworth Holdings has agreed to participate in order to maintain its overall ownership at approximately its current level. The timing and number of future shares repurchased under the share repurchase program will depend on a variety of factors, including Enact Holdings’ stock price and trading volume, and general business and market conditions, among other factors.
As the majority shareholder, Genworth Holdings received $61 million of capital returns from Enact Holdings in the first quarter of 2024. Enact Holdings’ capital allocation strategy includes supporting its existing policyholders, growing its mortgage insurance business, funding attractive new business opportunities and returning capital to its shareholders. Enact Holdings’ total return of capital will be based on this strategy as well as its view of the prevailing and prospective macroeconomic conditions, regulatory landscape and business performance.
On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under its existing share repurchase program that began in May 2022. Pursuant to the program, during the first quarter of 2024, Genworth Financial repurchased 10,240,670 shares of its common stock at an average price of $6.17 per share for a total of $63 million. Genworth Financial also authorized repurchases under its share repurchase program through a Rule 10b5-1 trading plan under which 1,933,444 shares of its common stock were repurchased in April 2024 for $12 million, leaving approximately $266 million remaining authorization under the share repurchase program as of April 30, 2024. Further repurchases under the program will continue to be funded from holding company capital, as well as future cash flow generation, including expected future capital returns from Enact Holdings. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions, or by other means, including through
108
Table of Contents
Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time.
Our future use of liquidity and capital will prioritize future strategic investments in CareScout and returning capital to Genworth Financial’s shareholders through share repurchases. We expect to continue to provide capital to CareScout to advance our strategic priority to develop innovative aging services and solutions. We may also from time to time seek to repurchase or redeem outstanding debt (with cash on hand, proceeds from the issuance of new debt and/or the proceeds from asset or stock sales) in open market purchases, tender offers, privately negotiated transactions or otherwise.
Genworth Holdings had $253 million and $350 million of unrestricted cash and cash equivalents as of March 31, 2024 and December 31, 2023, respectively. The decrease was principally driven by annual employee benefit payments that are expected to be offset by subsidiary expense arrangements during 2024, repurchases of Genworth Financial’s common stock and debt interest payments, partially offset by capital returns from Enact Holdings. We believe Genworth Holdings’ unrestricted cash and cash equivalents provide sufficient liquidity to meet its financial obligations over the next twelve months. However, we expect the amount of intercompany cash tax payments retained by Genworth Holdings from its subsidiaries to be lower starting in 2024 as compared to the amounts received during 2023. We also expect Genworth Holdings’ liquidity to continue to be impacted by the amounts and timing of Genworth Financial’s share repurchases as well as future dividends and other forms of capital returns from Enact Holdings.
We actively monitor our liquidity position (most notably at Genworth Holdings), liquidity generation options and the credit markets given changing market conditions. Genworth Holdings’ cash management target is to maintain a cash buffer of two times expected annual external debt interest payments. Genworth Holdings may move below or above this targeted cash buffer during any given quarter due to the timing of cash outflows and inflows or from future actions. Management of Genworth Financial continues to evaluate Genworth Holdings’ target level of liquidity as circumstances warrant.
Capital resources and financing activities
Our current capital resource plans do not include any additional debt offerings by Genworth Holdings or minority sales of Enact Holdings. The availability of additional capital resources will depend on a variety of factors such as market conditions, regulatory considerations, the general availability of credit, credit ratings and the performance of and outlook for Enact Holdings and the payment of dividends and other returns of capital therefrom.
During the first quarter of 2024, Genworth Holdings repurchased $6 million principal amount of its floating rate junior subordinated notes due in 2066 for a pre-tax gain of $1 million and paid accrued interest thereon. As of March 31, 2024, Genworth Holdings had $850 million principal of outstanding debt, with no maturities due until June 2034.
As of March 31, 2024, Enact Holdings had a credit facility that remained undrawn and $750 million principal amount of senior notes due in August 2025. Enact Holdings continually evaluates opportunities based upon market conditions to further increase its financial flexibility including through raising additional capital, restructuring or refinancing some or all of its outstanding debt or pursuing other options such as reinsurance or credit risk transfer transactions. There can be no guarantee that any such opportunities will be available on favorable terms or at all. Other than its senior notes due in August 2025, Enact Holdings has no material outstanding debt obligations that are expected to affect its liquidity over the next five years. We believe that the operating cash flows generated by Enact Holdings’ mortgage insurance subsidiaries will provide the funds necessary to satisfy its claim payments, operating expenses and taxes.
109
Table of Contents
Regulated insurance subsidiaries
The liquidity requirements of our regulated insurance subsidiaries principally relate to the liabilities associated with their various insurance and investment products, operating costs and expenses, the payment of dividends to us, contributions to their subsidiaries, payments of principal and interest on their outstanding debt obligations and income taxes. Liabilities arising from insurance and investment products include the payment of benefits and claims, as well as cash payments in connection with policy surrenders and withdrawals, policy loans and obligations to redeem funding agreements. Our insurance subsidiaries’ principal cash inflows from operating activities are derived from premiums, annuity deposits and insurance and investment product fees and other income, including commissions, cost of insurance, mortality, expense and surrender charges, contract underwriting fees, investment management fees, investment income and dividends and distributions from their subsidiaries. We manage our U.S. life insurance subsidiaries on a standalone basis. Accordingly, the U.S. life insurance subsidiaries will continue to rely on their statutory capital, significant reserves, prudent management of the in-force blocks and long-term care insurance in-force rate actions to satisfy policyholder obligations.
Given the challenging macroeconomic environment in 2023 and through the first quarter of 2024, employee costs were higher driven in part by wage inflation, the competitive labor market and low labor participation. Additionally, in our long-term care insurance business, we have observed an increase in the cost of care due in part to elevated inflation. These inflationary pressures have not had a significant impact on our liquidity to date; however, if these conditions persist for a long period of time, they could have a material adverse impact on our liquidity, results of operations and financial condition. We will continue to monitor macroeconomic trends, including inflation, to help mitigate any potential adverse impacts to our liquidity. We also expect overall claim costs to continue to increase over time in our long-term care insurance business as our blocks age, with peak claim years over a decade away.
Our insurance subsidiaries maintain investment strategies intended to provide adequate funds to pay benefits without forced sales of investments. Products having liabilities with longer durations, such as certain life insurance and long-term care insurance policies, are typically matched with investments having similar duration such as long-term fixed maturity securities and commercial mortgage loans. Shorter-term liabilities are typically matched with fixed maturity securities that have short-and medium-term fixed maturities. In addition, our insurance subsidiaries hold highly liquid, high quality short-term investment securities and other liquid investment grade fixed maturity securities to fund anticipated operating expenses, surrenders and withdrawals. As of March 31, 2024, our total cash, cash equivalents and invested assets were $61.0 billion. Our investments in privately placed fixed maturity securities, commercial mortgage loans, policy loans, bank loans, limited partnership investments and select mortgage-backed and asset-backed securities are relatively illiquid. These asset classes represented approximately 44% of the carrying value of our total cash, cash equivalents and invested assets as of March 31, 2024.
Off-balance sheet commitments, guarantees and contractual obligations
As of March 31, 2024, we were committed to fund $1,449 million in limited partnership investments, $119 million of bank loan investments, $28 million in commercial mortgage loan investments and $21 million in private placement investments.
As of March 31, 2024, there have been no material additions or changes to guarantees provided by Genworth Financial and Genworth Holdings or to our contractual obligations as compared to the amounts disclosed within our 2023 Annual Report on Form 10-K filed on February 29, 2024.
Supplemental Condensed Consolidating Financial Information
Genworth Financial provides a full and unconditional guarantee to the trustee and holders of Genworth Holdings’ outstanding senior and subordinated notes (registered securities under the Securities Act of 1933), on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the
110
Table of Contents
principal of, premium, if any and interest on, and all other amounts payable under, the outstanding senior and subordinated notes and their respective indentures. Genworth Holdings is a direct, 100% owned subsidiary of Genworth Financial.
Excluding investments in subsidiaries, the assets, liabilities and results of operations of Genworth Financial and Genworth Holdings, on a combined basis, are not material to the consolidated financial position or the consolidated results of operations of Genworth. In addition, none of Genworth Financial’s direct or indirect subsidiaries, other than Genworth Holdings, are issuers or guarantors of any guaranteed securities. Therefore, in accordance with Rule 13-01 of Regulation S-X, we are permitted, and we elected, to exclude the summarized financial information for both the issuer and guarantor of the registered securities.
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
Market risk is the risk of the loss of fair value resulting from adverse changes in market rates and prices, such as interest rates, equity prices and foreign currency exchange rates. Market risk is directly influenced by the volatility and liquidity in the markets in which the related underlying financial instruments are traded. There were no material changes in our market risks since December 31, 2023. See “—Business trends and conditions” and “—Investments and Derivative Instruments” in “Item 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations” for further discussion of recent market conditions, including changes in interest rates.
| Item 4. | Controls and Procedures |
Evaluation of Disclosure Controls and Procedures
As of March 31, 2024, an evaluation was conducted under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934). Based on this evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2024.
Changes in Internal Control Over Financial Reporting During the Quarter Ended March 31, 2024
During the three months ended March 31, 2024, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
111
Table of Contents
Item 1. |
Legal Proceedings |
Item 1A. |
Risk Factors |
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds |
(Dollar amounts in millions, except share amounts) |
Total number of shares purchased |
Average price paid per share |
Total number of shares purchased as part of publicly announced program |
Approximate dollar amount of shares that may yet be purchased under the program (1) |
||||||||||||
January 1, 2024 through January 31, 2024 |
2,231,991 | $ | 6.15 | 2,231,991 | $ | 328 | ||||||||||
February 1, 2024 through February 29, 2024 |
4,808,584 | $ | 6.13 | 4,808,584 | $ | 298 | ||||||||||
March 1, 2024 through March 31, 2024 |
3,200,095 | $ | 6.25 | 3,200,095 | $ | 278 | ||||||||||
Total |
10,240,670 | 10,240,670 | ||||||||||||||
(1) |
On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial could repurchase up to $350 million of its outstanding Class A common stock. On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under the existing program. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions, or other means, including through Rule 10b5-1 trading plans. The timing and number of shares repurchased under the program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time. For additional information on the share repurchase program, see “Part I—Item 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources.” |
Item 5. |
Other Information |
Table of Contents
| Item 6. | Exhibits |
| § | Management contract or compensatory plan or arrangement. |
113
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| GENWORTH FINANCIAL, INC. (Registrant) | ||||||
| Date: May 3, 2024 | ||||||
| By: | /s/ Darren W. Woodell | |||||
| Darren W. Woodell Vice President and Controller (Principal Accounting Officer) | ||||||
114